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PROFESSOR DEBRA T. AUGUSTE  MARJAN RAFAT 
 
DUAL ANTIBODY FUNCTIONALIZED POLYVINYL ALCOHOL AND ALGINATE 
HYDROGELS FOR SYNERGISTIC ENDOTHELIAL CELL ADHESION 
 
ABSTRACT 
 
Motivated by the need to design minimally-invasive treatments for wide-necked cerebral 
aneurysms, we used computational modeling to assess aneurysm hemodynamics, examined in 
vitro cellular responses arising from mechanical and chemical stresses, and designed novel 
materials that cooperatively adhere to the endothelium. We first hypothesized that because 
aneurysm geometry plays an important role in hemodynamics, changes in flow patterns may 
affect the shear stress experienced on the aneurysm wall. We defined flow regimes based on 
aneurysm hemodynamic and geometric parameters, which may correlate with aneurysm rupture. 
Because of the direct contact between endothelial cells (ECs) and blood flow, we then evaluated 
how changes in hemodynamics and inflammatory cytokines affect the expression of cell 
adhesion molecules (CAMs) and matrix remodeling factors on ECs. We subsequently designed 
biomaterials that complement the dynamic EC surface and have the ability to conform to any 
geometry through in situ crosslinking. Antibody-conjugated hydrogels facilitated synergistic EC 
adhesion using cooperativity as an adhesion strategy. We optimized the presentation of 
antibodies to inflammatory CAMs on polyvinyl alcohol (PVA) and alginate hydrogels to achieve 
strong adhesion to inflamed ECs. We synthesized photocrosslinkable, aminated PVA hydrogels 
and determined the effect of substrate stiffness on cell adhesion. We also evaluated the effects of 
antibody presentation on cell adhesion strength and dynamics using alginate hydrogels. Taken 
together, the results of this work may be used to design hydrogels for vascular remodeling 
applications under shear stress, including embolic agents for cerebral aneurysms. 
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1 INTRODUCTION 
1.1 Cerebral Aneurysms 
Weak areas in the walls of vasculature can expand to form blood-filled sacs called 
aneurysms, which are characterized as saccular (berry-like) or fusiform (spindle-shaped) [1]. 
This dissertation focuses on intracranial saccular aneurysms. Approximately 400 million people 
worldwide and 10-15 million people in the United States harbor unruptured saccular aneurysms 
that could potentially rupture at any time [2, 3]. Aneurysm size usually ranges from 2 to 25 mm 
but can reach 50 mm [4, 5].  The mechanisms behind aneurysm growth and rupture are 
unknown, creating difficulties in decision-making for treatment. An increased understanding of 
hemodynamics, mechanical forces, and biological remodeling within aneurysms is necessary for 
the discovery of improved treatment methods.  
Although the factors leading to aneurysm formation and growth are unidentified, it is 
speculated that genetics, hypertension, smoking, or biochemical disorders play an important role 
[1]. Each year approximately 30,000 aneurysms rupture in the United States, causing stroke, 
permanent nerve damage, or more commonly, subarachnoid hemorrhage (SAH). The mortality 
associated with SAH is 40% while less than 25% of the survivors recover fully from this disease 
[6]. The pathogenesis of saccular aneurysms is complex and involves the overlap of mechanical 
and biological factors that lead to the eventual rupture of the vessel. Finding a treatment that 
successfully prevents rupture is necessary for reducing the number of victims of this disease. 
Cerebral arteries differ from other arteries in that they do not possess an external elastic 
lamina, which provides added mechanical support to vessels. The propensity for aneurysm 
formation at or near the apex of a bifurcation is well-established [7]. Irregularities in the media 
and internal elastic lamina at the bifurcations of vessels could be a factor in aneurysm 
2 
 
pathogenesis [8]. It is also known that hemodynamic stresses, including pressure and shear, have 
a major function in the development of aneurysms. The pathogenesis of saccular aneurysms is 
complex and involves the overlap of mechanical and biological factors that lead to the eventual 
rupture of the vessel. 
 
1.2 Fluid Dynamics Studies 
The hemodynamics of vasculature is of paramount importance in aneurysm formation. 
Because of this, many studies have tried to recreate fluid flow in vitro in order to understand 
aneurysm pathology. Imbesi and Kerber have created clear elastic silicone replicas of fresh 
human cadaver ruptured arterial aneurysms and subjected them to physiological pulsatile flow 
[9]. Fluid slipstreams were observed in regions of vessel curvature, which may interact with the 
arterial bifurcation and lead to aneurysm formation. This study showed unique flows in 
geometrically valid aneurysms, but the lack of resemblance of the vessel in mechanical 
properties such as elasticity casts doubt as to whether or not this model is accurate in vivo. 
Wall shear stress is a key factor in aneurysm formation and expansion, so understanding 
how fluid shear stress impacts the vasculature walls is necessary. Shear stress has been evaluated 
in fully developed aneurysms with irregular shapes by constructing geometrically realistic 
acrylic models from three-dimensional (3D) computer tomographic (CT) angiography [10]. In 
addition, it was found that shear stress was not uniform in middle cerebral artery (MCA) 
aneurysm walls, and more realistic analysis of shear stress was attempted for comparison to the 
ideal spherical case. Another result from this study showed that the shear stress is highest in the 
tip of an aneurysm where blebs formed at 93% of the shear stress in the parent artery. However, 
a subsequent study used computational fluid dynamics (CFD) to create a mathematical model of 
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MCA aneurysms to quantify wall shear stress more accurately [11]. The research shows that the 
highest wall shear stress was found in the neck and not in the tip, where the shear stress was 
approximately 14 N/m2, four times higher than the parent vessel region. These conflicting results 
show how neglecting mechanical parameters of vessels like compliance and elasticity can 
severely affect the outcome of quantitative results. 
CFD is frequently used to analyze complex fluid behavior, which is especially significant 
to this research. We can no longer approximate shear stress using the Hagen-Poiseuille law 
because of the complex and dynamic nature of blood vessels. Accurate quantification of wall 
shear stress is critical for understanding the biological response of the vasculature to 
hemodynamics. Using Lagrangian interpolation functions and magnetic resonance imaging, 
Cheng et al. have created a blood vessel model to quantify wall shear stress to better account for 
physiological complexities [12]. Moreover, a CFD model has been developed to predict the flow 
structures in aneurysms comparable to traditional angiography [13]. Meng et al. reported that the 
initiation of aneurysm formation at the apices of bifurcations was caused by high wall shear 
stress and high shear stress gradients while Shojima et al. showed that low shear stresses in the 
sac may potentially contribute to the growth and eventual rupture of aneurysms [11, 14]. It is this 
complex dynamic that generates difficulties in understanding the pathologic mechanisms of 
aneurysms. 
Though all of the studies mentioned have added new and important information to the 
field, the analyses they present are incomplete because of their oversight of biological and 
vascular remodeling events that could dictate changes in fluid dynamics. For example, 
assumptions such as a rigid wall model and blood as a Newtonian fluid limit the accuracy and 
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reliability of the previously mentioned CFD models. Biological factors that coincide with 
hemodynamics as well as aneurysm progression are discussed in the next section. 
 
1.3 Using Hemodynamics to Understand Biology 
The process of aneurysm growth and rupture is a combination of physical and biological 
phenomena. Much of the literature on cerebral aneurysms concerns biological aspects of their 
formation and growth. Complex vascular wall modeling events may contribute to aneurysm 
development. Many groups have surgically created fully-formed aneurysms in animal models 
[15-20]. Meng et al., however, attempted to recreate aneurysm initiation in a canine model to 
monitor aneurysm growth [14, 21]. Consistent with the fact that aneurysms usually occur in areas 
of bifurcation in the vasculature, this group surgically created a bifurcation in the carotid 
vasculature and performed histological and CFD analyses after two weeks or two months. They 
claimed evidence of aneurysm growth and wall remodeling events such as hyperplasia and the 
disruption of the internal elastic lamina and medial layer at the apex of the bifurcation. It would 
have been more interesting to confirm formation by allowing the so-called aneurysms to grow in 
the canines and to further analyze whether or not this result was the product of surgery. Another 
group used CFD and physiological data to understand aneurysm growth [22]. They explored the 
hypotheses of shear stress-mediated loss of vascular tone through smooth muscle cell apoptosis 
and subsequent rupture, degradation, and reconstruction of the medial collagen and elastin fibers. 
The authors claimed that their model was able to predict aneurysm growth and correlate 
aneurysm development. Although this study gave insight into observed remodeling events, the 
simplified assumptions and lack of a physical model correlating with their results leave many 
unanswered questions for future studies. 
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Another major area of interest in this field is the examination of cellular and biological 
factors in areas of aneurysm formation and growth. The studies presenting this type of analysis 
aim to determine the biochemical events that are involved in aneurysm growth. Sadamasa et al. 
analyzed the role of endothelin B receptors (ETBRs) in aneurysm progression in rat models [23]. 
In this study, ETBRs were found to be involved in mechanically induced smooth muscle cell 
apoptosis. After aneurysm induction in rats, substantial ETBR expression was found in smooth 
muscle cells after 3 months of aneurysm induction. The administration of K-8794, a selective 
ETBR inhibitor, significantly reduced apoptotic smooth muscle cells and prevented complete 
aneurysm formation. Although ETBR may be important in aneurysm pathology of rats, analysis 
in human vasculature is imperative for the validation of this conclusion. Hemodynamic 
evaluation in vessels has not been done, so the quantification of shear stress at certain points of 
ETBR expression will be beneficial for a more complete understanding of this phenomenon.  
Additional studies exploring the biochemical basis of aneurysm formation have involved 
signaling molecules such as nitric oxide and interleukin-1β (IL-1β) [24, 25]. The role of 
inducible nitric oxide synthase (iNOS), a transcriptionally regulated nitric oxide producer that is 
expressed in humans and rat cerebral aneurysms, has been analyzed in a new iNOS knockout 
mouse model. After subjecting iNOS knockout mice to an aneurysm induction procedure, iNOS 
was not deemed necessary for aneurysm initiation; however, it was involved in aneurysm growth 
and smooth muscle cell apoptosis. Furthermore, IL-1β is a proinflammatory cytokine involved in 
iNOS activation. The production of IL-1β knockout mice showed that IL-1β is important in 
aneurysm progression but not initiation, similar to the effect seen with iNOS. Thus, iNOS and 
IL-1β molecules may be significant in the understanding of aneurysm pathological development. 
Matrix remodeling elements including matrix metalloproteinases (MMPs), which are involved in 
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the degradation of extracellular matrix (ECM) components, have also been studied in the 
aneurismal context because of their role in medial wall thinning and disruption of the internal 
elastic lamina. For example, Aoki et al. evaluated the effect of MMP2 and 9 expression in rats 
[26]. An inflammatory response in induced aneurysms caused macrophages to express MMP2 
and 9, which contributed to aneurysm progression. Because this research was only conducted in 
mouse and rat models, it will be difficult to predict whether or not human aneurysm development 
is managed by the same factors. Another important consideration in this pathobiology is 
complement activation [27]. Tulamo et al. showed that membrane attack complex deposition is 
associated with wall degeneration and rupture in cerebral aneurysms in humans. This study 
determined that complement activation may be involved in both the progression and rupture of 
aneurysms and suggested that complement-mediated cell death may likely be independent of 
apoptotic mechanisms. Some complexities of aneurysm development have been elucidated here. 
Given the findings of the above studies, the use of anti-inflammatory agents to prevent 
destructive tissue remodeling may be important in aneurysm treatment. 
Since endothelial cells (ECs) come in direct contact with blood flow, understanding their 
biochemical response to physical flows is essential. Malek et al. conducted extensive studies on 
the biological response of ECs due to fluid flow and shear [28-32]. In one study, they exposed 
monolayers of bovine aortic ECs to physiological fluid shear stresses of 4, 15, 20, or 36 
dynes/cm2 with a cone-plate viscometer, allowing the cells to experience steady laminar, 
turbulent, and pulsatile shear stresses. Thrombomodulin, a thrombin-binding EC surface receptor 
involved in thrombosis protection, was found to be downregulated by shear, while fibrinolytic 
tissue plasminogen activator was increased, demonstrating the dynamic response of ECs under 
flow conditions. Shear was shown to regulate EC expression of endothelin-1 (ET-1), basic 
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fibroblast growth factor (bFGF), and platelet-derived growth factor B (PDGF-B) mRNA. ET-1, a 
potent vasoconstrictor, was downregulated up to five fold in response to shear stress. PDGF-B, a 
mitogen and vasoconstrictor, was downregulated while bFGF, a growth and migration regulator, 
was upregulated due to shear. These studies showed that the morphology of vascular ECs was 
sensitive to shear since high shear stress resulted in spindle-like cell shape. In another study, 
endothelial nitric oxide synthase (eNOS), which synthesizes the vasodilator nitric oxide and is 
involved in vascular remodeling, was found to be modulated by physical and chemical factors. 
Steady shear stress increased eNOS levels while hydrostatic pressure, hypoxia, and high glucose 
decreased levels. These studies have not shown significant changes in trends of gene expression 
when comparing flow character (steady, pulsatile); rather, gene expression was dependent on 
shear stress magnitude and exposure time. This result is surprising, and it may be true for the 
specific factors analyzed under the conditions described. However, it should be noted that the 
experimental set-up used in these studies differs vastly from in vivo conditions. Because of this 
discrepancy, a more comprehensive study detailing other important factors in EC regulation and 
response to shear is necessary along with a more physiologically relevant method of inducing 
shear. Nevertheless, these results elucidate the complexities of EC biochemistry as well as vessel 
remodeling characteristics, which will be useful for understanding the development of 
aneurysms. 
 Many of the studies dealing with the biochemical responses implicated in vascular 
remodeling and aneurysm pathology are incomplete. Some studies only consider biochemical 
factors and gene expression with little emphasis on hemodynamic quantification whereas others 
look to CFD or in vitro results without sufficient in vivo validation. It is especially difficult to 
draw conclusions from studies based on animal experiments, as it is unclear whether human 
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vasculature differs. Further studies that involve adequate combinations of physical and biological 
analysis that closely correlate with in vivo conditions should be conducted so that the 
fundamental mechanisms of aneurysm formation and growth can be better understood. 
 
1.4 Current Aneurysm Treatments and Limitations 
There are two common methods of aneurysm treatment: microvascular clipping and 
endovascular embolization. Microvascular clipping involves a highly invasive craniotomy where 
the aneurysm neck is directly clipped to block blood flow. Although this technique is broadly 
used for preventing aneurysm rupture, its highly invasive nature poses risks for procedural 
complications and patient disability [33]. The less invasive technique of endovascular 
embolization utilizes the packing of platinum Guglielmi detachable coils directed through a 
catheter in the aneurysm in order to prevent rupture. Although this procedure has emerged as an 
acceptable alternative to surgery in many cases, the inability to treat wide-necked, large, or giant 
aneurysms via endovascular embolization is a major obstacle. The possibility of coil herniation 
into the parent vessel, incomplete aneurysm occlusion, and aneurysm recanalization creates 
difficulties in this treatment [34]. Both microvascular clipping and endovascular embolization 
have failure rates between 5-20% (from discussions with Dr. James Rabinov, Massachusetts 
General Hospital). Therefore, improvements upon these techniques or new minimally-invasive 
strategies need to be designed to enable treatment of a wide variety of aneurysm geometries.  
Novel materials that can be used in situ for aneurysm occlusion via minimally-invasive 
strategies are highly desirable. Microvascular clipping or endovascular embolization are either 
too invasive or cannot be used for all aneurysm sizes and shapes [33, 34]. In a recent study, 
clipping has been found to be used more clinically than coiling despite the increased hospital 
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complications and mortality rates associated with clipping [35]; this is likely due to aneurysm 
geometries unfavorable for coiling [36]. A minimally-invasive endovascular method for 
aneurysm treatment that can be used for all aneurysm geometries is necessary to prevent the risks 
related to clipping. 
There are many limitations to the endovascular embolization technique that uses bare 
platinum coils, including inability to fill the aneurysm completely and delayed thrombus and 
organized tissue formation, which leave the area susceptible to recanalization and rupture [37]. 
To address these obstacles, a variety of systems of coils are being investigated for improving the 
vascular embolization technique. The HydroCoil system, for example, increases the coil packing 
density through the pH sensitive polymethacrylic acid hydrogel that expands when released into 
the aneurysm [38]. Additionally, the matrix detachable coil uses the biodegradable copolymer 
poly(lactic-co-glycolic acid) in order to induce an inflammatory response for acceleration of 
aneurysm healing through smooth muscle cell migration and thrombus organization [39]. Other 
variations such as nylon fibered and polyglycolic acid coated coils have been used in the clinic 
[40, 41]. It was found, however, that none of the methods discussed provided a significant 
improvement over the bare coil technique and therefore are not warranted for use in the clinic 
due to increased costs and unknown long-term effects in general [42]. 
In more iterations of the original bare platinum coil, coatings that incorporate drug 
delivery methods and bioactivity have been investigated [37]. The idea here is an extension of 
the original goal: include a gel to fill the aneurysm space with an agent that promotes cell growth 
and healing. One such study used platinum coils with bFGF within a polyvinyl alcohol (PVA) 
core to encourage cell proliferation and increased wall thickness [43].  Another study used 
platinum coils embedded with fibroblast cells for fibrosis induction [44]. Despite the fact that 
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these methods increased packing and accelerated tissue organization, they provided no 
considerable advantage in practice. They had many of the same limitations as the current 
treatment methods, including potential for parent artery stenosis, induction of detrimental 
inflammatory responses, and precipitation of thromboembolic events [37]. 
To address the problem of not being able to use coils with large or wide-necked 
aneurysms, endovascular stent-assisted coiling technologies have emerged. The Neuroform stent 
can be placed in the intracranial aneurysm area to create a barrier for coils to be packed tightly 
within aneurysms [45]. Other advantages of this technique are that the stent can prevent blood 
flow from entering the aneurysm and that it can create a potential scaffold for cell in-growth, 
which may facilitate tissue organization events [37]. However, this technique is limited by 
technical challenges and is sometimes impossible to use for certain vessel geometries, and many 
thromboembolic complications have been reported [46]. More recently, the Cordis Enterprise 
stent system has been implemented with the characteristics of a closed-cell design, which may 
enable greater mobility and control within the vasculature during intraoperative procedures [47]. 
Further clinical research needs to be done to prove the efficacy of this technique, but its 
thrombogenic properties still remain a challenge. 
Variations of coiling mechanisms are not the only avenues being explored for the 
treatment of aneurysms. For example, a recent study proposed the use of an endovascular clip 
system (eCLIPs) that combined the concepts of microvascular clipping and stent technology 
through a flexible device that is anchored at the aneurysm neck and can expand to occlude the 
aneurysm area and deflect blood flow [48]. No clinical trials have yet been done with this device. 
Liquid embolic agents are also being explored for treatment technologies. The Onyx liquid 
embolic system consists of ethylene vinyl alcohol in dimethyl sulfoxide and precipitates in situ 
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upon entering the vessel [49]. This technique is widely used in the treatment of arteriovenous 
malformations. The liquid can conform to any aneurysm shape and completely occlude the area. 
However, the agent is not bioactive and is difficult to administer; alternative ideas are needed to 
improve upon these limitations [37].  
   Many groups have tried to improve upon current aneurysm treatment techniques in 
incremental steps. Endovascular embolization is becoming the preferred method of aneurysm 
treatment over surgical clipping based on the International Subarachnoid Aneurysm Trial [50]. 
Furthermore, the Cerebral Aneurysm Rerupture After Treatment study concluded that complete 
aneurysm occlusion should be pursued to minimize risks of aneurysm rupture [51]. Considering 
the limitations of current technologies and the characteristics desired in an optimal aneurysm 
treatment, we can imagine a new treatment technology that uses a bioactive gel that forms in situ 
to conform to the aneurysm geometry, fills and adheres to the entire space, and diverts the blood 
flow away from the area to facilitate healing. 
 
1.5 Inflammation and Endothelial Cells 
Upon incitement of the inflammatory cascade due to infection or tissue damage, 
leukocytes adhere to the EC lining of the vessel wall via the presentation of specific surface 
molecules [52]. The expression of endothelial-leukocyte adhesion molecules, including 
endothelial leukocyte adhesion molecule-1 (E-selectin), vascular cell adhesion molecule-1 
(VCAM1), and intercellular adhesion molecule-1 (ICAM1), indicates EC “activation” and 
mediates the progression of the inflammatory process. The inflammatory process has been 
elucidated: leukocytes are recruited to inflamed areas and proceed to roll and tether to the 
endothelium. They then adhere firmly and move to cell junctions where they finally transmigrate 
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across the endothelial barrier [53-59]. Several key cell adhesion molecules (CAMs) are involved 
in this process. E-selectin, an endothelial glycoprotein that supports adhesion of neutrophils, 
monocytes, and eosinophils, is expressed in response to inflammatory cytokines such as 
interleukin-1 (IL-1) and tumor necrosis factor (TNF). E-selectin is implicated in the tethering and 
rolling of leukocytes during the inflammatory cascade. In addition, VCAM1 and ICAM1 are 
both immunoglobulin (IgG) CAMs upregulated upon exposure to inflammatory stimuli [60, 61]. 
These CAMs are responsible for the firm adhesion of cells to the endothelium and their 
migration to cell junctions [62]. The enhanced expression of inflammatory cell adhesion 
molecules is a hallmark of many diseases, including atherosclerosis [63-65], ischemia and 
reperfusion injury due to myocardial infarction or stroke [66-68], and cerebral aneurysms [62, 
69].  
Because the innermost lining of blood vessels is comprised of ECs [70], materials 
implanted into the vasculature come into extensive contact with ECs [71]. Cellular adhesion, 
proliferation, migration, and differentiation are directly influenced by the interactions between 
cells and their external environment. Soluble and bound chemical molecules as well as physical 
cues can regulate this behavior [72]. Understanding the EC response in the inflammatory 
environment can improve the interactions of biomaterials with the vasculature, particularly with 
inflamed endothelium. 
 
1.6 Cell Adhesion Strategies in Tissue Engineering 
   The field of tissue engineering seeks to design strategies for the improvement or 
replacement of biological function. One fundamental concern in designing tissue engineering 
scaffolds is the adhesion and recruitment of cells. The advent of the specific cellular recognition 
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sequence peptide arginine-glycine-aspartic acid (RGD) that comprises the adhesion domains of 
fibronectin and other ECM glycoproteins has facilitated cell adhesion on synthetic materials 
[73]. The ability of cells to adhere to materials and subsequently migrate is necessary for 
angiogenesis and regenerative processes [74]. The density of cell adhesion peptides has been 
examined: if there are too few ligands, cells cannot successfully adhere and integrate into the 
material; if surfaces are saturated with adhesion peptides, cells cannot migrate effectively [75]. 
Thus, the density of adhesive ligands must be balanced for optimal cell function within 
biomaterials. 
Cell adhesion to materials can be enhanced through engineering of ligand presentation on 
synthetic materials. The cellular response to bound signals from the ECM has been explored 
extensively [76]. The ECM is composed of protein fibers integrated within a network of 
glycosaminoglycan chains that provide structural support. Cellular processes can be controlled 
by mimicking the structure of the ECM in biomaterials [77]. Peptides from larger proteins found 
in the ECM are commonly used as cell adhesion targets because transmembrane cellular 
receptors can interact with these ECM adhesion ligands to promote binding [78]. 
An alternative approach involves modifying materials with antibodies complementary to 
CAMs expressed during inflammation [79]. The upregulation by ECs of specific CAMs in 
response to inflammation has been well-characterized. While CAMs are usually used to mediate 
interactions between ECs and inflammatory cell subsets, it may be possible to exploit CAM 
expression for biomaterials design. Specifically, the EC expression responses of E-selectin, 
VCAM1, and ICAM1 during exposure to inflammation-mimicking stimulation are of interest. 
Each of these molecules is involved in cell adhesion, recruitment of leukocytes, or tissue 
remodeling [52, 80], and they are the CAMs most commonly expressed on activated 
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endothelium. Presentation of antibodies against E-selectin, VCAM1, and ICAM1 on materials 
surfaces could allow for engineering of preferential binding of activated ECs. Because antigen-
antibody interactions are known to allow for firm adhesion under flow [81], such interactions 
could further provide for effective adhesion that resists weakening due to hemodynamic forces. 
 
1.7 Cooperativity in Biology 
   Cooperativity observed in biology links individual molecular interactions to system level 
properties [82]. Cooperativity is a biophysical phenomenon in which the binding of one ligand 
increases the probability that other ligands will bind [83]. In cooperativity that is due to 
polyvalency, the binding of one ligand makes subsequent interactions more favorable by 
reducing the number of nonproductive configurations and the entropic penalty of binding each 
additional ligand. Thus, multiple
   Cooperative binding is widely observed in biological systems. It is most highly evident 
among proteins and glycans and can occur in solution or on cell membrane surfaces. Numerous 
studies have also reported a decrease in the dissociation constant when a third molecule is used 
to enhance binding between two other molecules.  For example, bFGF has bound cell surface 
receptors cooperatively with the help of heparin sulfate proteoglycans [
 receptor-ligand interactions yield an overall strong adhesion. 
84].  
   Mimicking cooperative interactions on synthetic matrices has only recently been 
employed in drug delivery [85-87]. Cooperative cell binding of receptors to molecules allows for 
enhanced adhesion strength, possibly due to the fact that multiple ligand-receptor bonds need to 
be broken simultaneously in contrast to independent adhesion where bonds rupture sequentially 
[88]. In this dissertation, we explored the conditions that would facilitate cooperative binding 
and promote strong, synergistic adhesion of cells to biomaterials. 
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1.8 Thesis Hypothesis and Experimental Strategy 
We hypothesized that by understanding how hemodynamics and biological response are 
coupled in aneurysms, we may be able to design a new occlusion strategy. We have used 
computational modeling, evaluation of the response of EC surface markers, and the fabrication 
of novel biomaterials to explore new embolic materials. This dissertation is composed of three 
aims; an overview of each aim is described below. A list of publications resulting from the work 
described in this dissertation is shown in Appendix A. 
Aim 1 is focused on defining flow regimes based on the hemodynamic and geometric 
parameters of aneurysms. We hypothesized that changes in flow patterns may affect the shear 
stress experienced on the aneurysm wall, which may correlate to rupture. Because aneurysm 
geometry plays an important role in hemodynamics, we used this idea to model changes in 
hemodynamics within varying aneurysm geometries computationally. 
 In aim 2, we coupled hemodynamics and biological response in vitro. Changes in shear 
stress and the inflammatory environment may alter EC expression of CAMs and matrix 
remodeling factors. We evaluated the effect of shear stress and inflammatory cytokines on EC 
gene and protein expression. We then used this information to design hydrogels that may adhere 
to the vascular endothelium, as detailed in the final aim. 
 Finally, we explored the use of hydrogels as aneurysm occlusion materials in aim 3. We 
showed that antibody-conjugated hydrogels may promote synergistic EC adhesion using 
cooperativity as an adhesion strategy. We built upon the existing idea of liquid embolization 
using novel materials that promote cell adhesion. This technique is unique from the other 
treatments discussed previously in that it includes the ability for adhesion to the aneurysm area 
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through a bioactive mechanism. We addressed the limitations of previous treatment methods, 
namely complete occlusion, ease and rapidity of procedure, and strong cell adhesion. To this end, 
we have synthesized photocrosslinkable polyvinyl alcohol (PVA) hydrogels as well as alginate 
hydrogels that are conjugated with antibodies to CAMs that complement EC surface expression 
during the inflammatory response. These modified hydrogels can form in situ, conform to any 
geometry, and exhibit strong, synergistic adhesion to activated ECs. 
 
  
17 
 
2 PROBING GEOMETRY AND HEMODYNAMICS IN ANEURYSMS 
2.1 Introduction 
   Recent studies of aneurysm hemodynamics focus on a limited number of geometries or 
Reynolds numbers (Re) that cannot be applied to a wide range of patient-specific cases.  In this 
section, we analyzed flow patterns and wall shear stress (WSS) using non-dimensional analysis 
in order to assess a range of clinically relevant, idealized geometries and Re to characterize the 
hemodynamic landscape and transition boundaries between distinct flow patterns.  Geometries 
were altered by increasing the height to width (HA/WA) ratio of the aneurysm and neck width to 
parent vessel width (WN/WP) ratio, which have been identified as significant in prior clinical 
studies.  Aneurysms were centered at the midpoint of a bifurcation, offset from the bifurcation 
midpoint, and located on a sidewall vessel.  We demonstrated that at constant geometry small 
changes in Re can alter hemodynamics.  We observed a prevalence of eddies at low WN/WP and 
high HA/WA for all aneurysm types.  For constant geometries, areas of low WSS (<0.01 N/m2) 
decreased with increasing Re for centered aneurysms, but offset and sidewall aneurysm areas 
remained unchanged.  We have identified how hemodynamic patterns and transitions correlate 
with geometry and Re, which may be useful in the study of aneurysm pathophysiology. 
Predictions of aneurysm growth and rupture may be achieved by understanding the fluid 
and solid mechanics of blood flow and vessel structure.  We used numerical methods to study 
flow patterns in clinically relevant, idealized aneurysm geometries whose significance has been 
suggested by recent clinical studies that relate hemodynamics (Re from 0-500 and flow patterns), 
geometry, and wall shear stress (WSS) [89]. 
Numerical simulations, computational fluid dynamic (CFD) models, and geometric 
analyses are among the many approaches taken to study the pathophysiology of aneurysms.  
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These hemodynamic studies have attempted to elucidate distinguishing flow features of 
aneurysms.  One analysis used the finite-element method (FEM) to determine the velocity fields 
in wide and narrow necked aneurysms under pulsatile flow at two Re [7].  They speculated that 
eddy formation in the center of the aneurysm may contribute to thrombus formation or cell 
aggregation, which can lead to growth and rupture of an aneurysm.  FEM was also used in a two-
dimensional (2D) model of sidewall aneurysms under steady flow [90].  The magnitude of shear 
stress on the aneurysm wall was shown to depend on the geometry, which suggests that the shape 
of the aneurysm influences aneurysm growth.  These and other studies agree that aneurysm 
hemodynamics are a function of the geometry and Re [1]. The outcome of these hemodynamic 
changes is unclear, but only limited simulations for a small number of geometries have been 
reported. 
Several hypotheses have been made that link geometric factors to aneurysm rupture [89-
92]. The risk of rupture in patient-specific aneurysm geometries has been evaluated using a CFD 
model based on three-dimensional (3D) angiographs of real patients.  Complex flows and narrow 
inflow jets are shown to be characteristic of ruptured aneurysms [91]. A correlation between an 
elliptical shape factor and WSS has indicated an increased susceptibility to rupture [92].  
Statistical analysis in patients with both unruptured and ruptured aneurysms revealed that 2D 
shape factors correlated with sidewall aneurysm rupture [89].  We have built upon this work by 
describing the hemodynamic phenomena (i.e. WSS, approximate flow fields) that arise due to 
changes in aneurysm geometries identified as significant in these studies.  We observed flow 
pattern transition boundaries as a function of geometry and Re, which could lead to the 
correlation between aneurysm shape and rupture for diagnostic purposes. 
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This brief survey shows that many unanswered questions remain for elucidating the link 
between hemodynamic features, aneurysm geometry, and rupture.  Though it is generally 
accepted that hemodynamics is important in understanding the fate of aneurysms, most studies 
focus on a limited number of geometries and flow rates. This does not allow extension of the 
conclusions to a wide range of aneurysms.  We have probed the relationship of aneurysm 
geometry to flow patterns using non-dimensional terms, which allows for broad application of 
our data to patient-specific aneurysms.  Our findings have shown that flow characteristics are 
sensitive to changes in geometry and Re.  Additionally, because WSS has previously been 
implicated in aneurysm growth and rupture, we evaluated how the shear stress at the aneurysm 
wall relates to differences in geometry [93].  Our systematic evaluation of aneurysm 
hemodynamics may be useful in correlating common features amongst computational 
investigations that focus on patient-specific data.  This work may provide insight into aneurysm 
pathophysiology. 
 
2.2 Methods and Materials 
In this study, a “flow mapping” scheme is presented to evaluate geometric features of 
saccular aneurysms over a range of Re.  We have categorized aneurysm geometries by their 
height to width (height of the aneurysm/width of the aneurysm or HA/WA) and neck to parent 
(width of the aneurysm neck/width of the parent vessel or WN/WP) ratios (Fig. 2.1A).  Flow 
patterns were evaluated for aneurysm geometries centered on a bifurcating vessel, offset from a 
bifurcating vessel, and located on a sidewall vessel.  Table 2.1 depicts the heights and widths of 
all aneurysm geometries used in the simulations.  For each flow map, eleven Re (0.5, 1, 5, 10, 
50, 100, 150, 200, 250, 300, and 500) and four WN/WP ratios (approximately 0.25, 0.5, 1, and 
20 
 
1.5) were analyzed.  Flow maps have been created for HA/WA ratios of 0.5, 1, 1.25, 1.5, and 1.75.  
WSS profiles were examined upon changing geometries; three HA/WA ratios and two Re were 
evaluated for each type of aneurysm. 
 
Table 2.1: Aneurysm dimensions used in simulations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HA/WA Height (mm) Width (mm) 
 0.5 1 
 0.5 1 2 
  2 4 
  3 6 
 1 1 
1  2 2 
  4 4 
  6 6 
 1.25 1 
1.25  2.5 2 
  5 4 
  7.5 6 
 1.5 1 
1.5  3 2 
  6 4 
  9 6 
 1.75 1 
1.75  3.5 2 
  7 4 
  10.5 6 
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Aneurysm geometry 
Schematics of the geometries of the aneurysms used in our computational modeling are 
shown in Figures 2.1A, 2.1C, and 2.1D.  Physiological widths for the parent (entrance channel) 
and daughter vessels (branching or bifurcating channels) are 4 mm and 3 mm, respectively [7].  
We have set the lengths of the parent and daughter vessels at 30 and 13 mm, respectively.  
Figures 2.1C and 2.1D show representative images for offset and sidewall aneurysms.  We have 
additionally made a 2D model of a basilar artery aneurysm based on an angiogram image to 
confirm how our flow maps could potentially be extended to other geometric variations (Fig. 
2.1Ei and 2.1Eii).  ImageJ was used to extract the length scale information from the angiogram; 
the HA/WA and WN/WP ratios were found to be 1.0 in both cases. 
Flow was characterized by the dimensionless Re (Eq. 2.1). 
η
ρ uWP=Re  (2.1), 
where ρ is the density, WP is the width of the parent vessel, u  is the mean velocity, and η is the 
fluid viscosity.  We focus on a physiological range of 100<Re<400 [94]. 
Computational model 
We numerically solved the Navier-Stokes (Eq. 2.2) and continuity (Eq. 2.3) equations 
assuming incompressible flow of a Newtonian fluid using the COMSOL 3.3 Multiphysics FEM 
software: 
𝜌 �
𝜕𝒖
𝜕𝑡
+ (𝒖 ∙ ∇)𝒖� = −∇𝑝 + 𝜂∇2𝒖 (2.2)  
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∇ ∙ 𝒖 = 0 (2.3), 
where p is the pressure, u is the velocity vector, and η is the fluid viscosity.  Blood density and 
viscosity are typically 1060 kg/m3 and 3 cP, respectively [95, 96].  We assumed 2D, steady  
(𝜕𝒖
𝜕𝑡
= 0), laminar flow in a rigid wall model of a vessel [7, 92, 97]. The no slip condition was 
applied at the wall. The MATLAB code used to run simulations in COMSOL is shown in 
Appendix B. 
WSS profiles were calculated along the aneurysm boundary arc length for varying 
HA/WA and Re (100 and 400).  It is convenient to present these results by reporting the arc length 
ratio, by which we denote the fraction of the arc length that experienced low shear stress (< 0.01 
N/m2).  The results utilize an arc length that is non-dimensionalized by the parent vessel width. 
The geometries were resolved with a fine mesh with a minimum of 7,400 elements (Fig. 
2.1B).  Special attention was paid to the region of the aneurysm and the corners, and we 
confirmed that the streamlines and WSS profiles converge by using both coarser and finer 
meshes. 
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Figure 2.1: Geometric parameters. (A) Centered aneurysm model and definition of parameters. 
The height (HA) and width (WA) of the aneurysm are indicated by solid vertical and horizontal 
lines, respectively. The width of the neck (WN) and parent vessel (WP) are respectively shown by 
a dashed horizontal line and arrows. (B) Typical mesh used to resolve the aneurysm geometries.   
(C) Representative offset aneurysm. (D) Representative sidewall aneurysm. (E) i) Angiogram of 
basilar artery aneurysm. ii) Computational model geometry of angiogram. 
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By visually inspecting various streamline patterns, we have created flow maps by plotting 
WN/WP versus Re for multiple HA/WA values and qualitatively demarcating the transitions 
between streamline patterns.  Mapping of the distinct flow patterns defined common 
characteristics that appear as a function of Re and geometry.  Representative images of the 
aneurysm geometry were placed at the bottom of each graph for visualization of WN/WP.  Flow 
asymmetry was relative to the midpoint line of the aneurysm centered on the aneurysm neck.  
The physiologically relevant Re range is located between the dashed lines. 
We have categorized flow patterns based on geometry and flow characteristics.  Our 
assumptions allowed us to perform simulations that identify macroscopic flow features and 
transition boundaries which correlate with patient-specific aneurysms.  Similar assumptions of 
2D geometry, steady flow, and rigid walls have been used in a variety of flow studies [7, 90, 97-
99]. Our focus in this study is on the systematic organization of hemodynamic patterns into 
“flow maps” which categorize qualitatively distinct flow features and transition boundaries.  In 
this approach, the assumptions made are reasonable to describe the qualitative features of flow.  
There are significant differences between 2D and 3D hemodynamic studies; however, 
similarities exist among the qualitative flow patterns [100].  It has been previously shown 
through experiment and computational models that pulsatile character does not affect flow 
characteristics qualitatively [97, 98, 101-103].  In addition, vessel elasticity has been shown to 
not significantly alter flow patterns or the average velocity within aneurysm geometries [7, 90, 
99, 100, 103, 104].  It is not our position that these simulations mimic clinical aneurysms exactly 
but that analysis of aneurysm shape factors and flow conditions in a systematic fashion can be 
used to recognize common hemodynamic patterns and transition boundaries. 
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2.3 Intra-Arterial Flow Patterns in Symmetric Aneurysms 
Six characteristic flow patterns (Fig. 2.2) were found commonly upon altering the 
aneurysm geometry (HA/WA, WN/WP) and Re (defined in Fig. 2.1A).  These patterns were 
distinguished qualitatively by having symmetrical (Fig. 2.2A) and asymmetrical (Fig. 2.2B) 
streamline patterns.  The patterns showed the formation of eddies (Fig. 2.2Ai, 2.2Bi), penetrating 
bifurcating jets (Fig. 2.2Aii, 2.2Bii), and penetrating bifurcating jets with eddies (Fig. 2.2Aiii, 
2.2Biii).  
 
 
 
 
 
 
 
Figure 2.2: Representative streamlines. (A) Symmetric flow streamlines.i) Eddies (Re=0.5, 
HA/WA=1, WN/WP=0.25) ii) Penetrating bifurcating jets (Re=500, HA/WA=0.5, WN/WP=0.5) iii) 
Penetrating bifurcating jets with eddies (Re=200, HA/WA=1.5, WN/WP=0.4) (B) Asymmetric 
flow streamlines. i) Asymmetric eddies (Re=1, HA/WA=1.75, WN/WP=0.2) ii) Penetrating 
bifurcating jets (Re=500, HA/WA=1.5, WN/WP=1) iii) Penetrating bifurcating jets with eddies 
(Re=150, HA/WA=1.75, WN/WP=1.5). 
 
A ii) iii) i) 
B iii) i) ii) 
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We graphically depicted flow patterns for constant HA/WA as a function of WN/WP vs. Re 
for centered aneurysms.  For HA/WA=0.5 (Fig. 2.3A), we observed a combination of penetrating 
bifurcating jets and eddies at low WN/WP and Re (0.2<WN/WP<0.5 and Re<150).  Beyond this 
regime, only penetrating bifurcating jets were seen. Aneurysms with HA/WA=1 (Fig. 2.3B) 
resulted in the presence of eddies at low Re (<100) and low WN/WP (<0.5). Penetrating 
bifurcating jets with eddies were found at intermediate values of Re (100<Re<300) for 
WN/WP<0.5 and at low Re for WN/WP>0.5.  Asymmetric bifurcating jets dominated at large Re 
for HA/WA =1.  Mappings of HA/WA=1.25 or 1.5 (Appendix B, Fig. 8.1) had similar profiles to 
the results for HA/WA=1.  At HA/WA=1.75 (Fig. 2.3C), the appearance of asymmetric eddies at 
low WN/WP was approximately independent of Re.  Bifurcating jets with eddies existed beyond 
WN/WP>0.5 but only below physiologically relevant Re (100<Re<400).  Asymmetric bifurcating 
jets with eddies were observed for physiological Re over a large range of WN/WP 
(0.4<WN/WP<1.5). 
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Figure 2.3: Qualitative mapping of flow patterns in symmetric aneurysms. Flow maps are 
shown in terms of various aneurysm height to width (HA/WA) ratios, Reynolds numbers (Re), 
and neck to parent width (WN/WP) ratios for symmetric aneurysms: (A) HA/WA=0.5 (B) 
HA/WA=1 (C) HA/WA=1.75. Dashed lines indicate physiological Re. 
A 
C 
B 
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We have created a center terminated model of a basilar artery aneurysm (i.e. aneurysm 
with angled daughter vessels) with HA/WA=1 and WN/WP=1 to mimic the angiograph presented 
in Fig. 2.1Ei. For the range of Re considered (0<Re<500), all flows were asymmetric.  We have 
determined that although the angles of the arms were not perpendicular to the parent vessel, the 
transition from penetrating bifurcating jets with eddies to bifurcating jets at Re=50 was similar to 
the symmetric aneurysm flow map with HA/WA=1 (Fig. 2.3B). 
 
2.4 Offset Aneurysms 
 We have studied flow patterns that arise in aneurysms offset from the inflow (Fig. 2.1C).  
The characteristic flows in this geometry consisted of eddies, penetrating jets, or penetrating jets 
with eddies (Fig. 2.4Ai-iii).  For HA/WA=0.5 (Fig. 2.4B), two types of flows were observed: 
penetrating jets with eddies at low WN/WP and penetrating jets when WN/WP>0.5. When 
HA/WA=1, the flow map was dominated by penetrating jets with eddies except for a region of 
penetrating jets below physiological Re, 0<Re<60, and WN/WP>1 (Fig. 2.4C).  The mappings of 
HA/WA=1.25 and 1.5 (Appendix B, Fig. 8.2) were similar to graphs for HA/WA=1.75 (Fig. 
2.4D).  The map displayed penetrating jets with eddies, except for a region of eddies at low Re 
(0<Re<50) and WN/WP (0.2<WN/WP<1). 
 
 
 
 
29 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Flow mapping of offset aneurysms. (A) Examples of flow patterns in offset 
aneurysms. i) Eddies (Re=10, HA/WA=1.5, WN/WP=0.2) ii) Penetrating jets with eddies (Re=10, 
HA/WA=1.5, WN/WP=1) iii) Penetrating jets (Re=200, HA/WA=0.5, WN/WP=0.5). Flow mapping 
in terms of various aneurysm height to width (HA/WA) ratios, Reynolds numbers (Re), and neck 
to parent width (WN/WP) ratios: (B) HA/WA=0.5 (C) HA/WA=1 (D) HA/WA=1.75. Dashed lines 
indicate physiological Re. 
A 
C 
B 
D 
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2.5 Sidewall Aneurysms 
Over the entire range of HA/WA, asymmetric flows dominated flow patterns in sidewall 
aneurysms (Fig. 2.1D).  The characteristic asymmetric flows consisted of penetrating jets with 
eddies (Fig. 2.5Ai), eddies (Fig. 2.5Aii), or layered eddies (Fig. 2.5Aiii).  For HA/WA=0.5 (Fig. 
2.5B), asymmetric eddies dominated the map except for a small area of penetrating jets with 
eddies below physiological Re (Re<10).  Similarly, HA/WA=1 (Fig. 2.5C) predominantly had 
asymmetric eddies with an area of eddies (WN/WP<0.2 and 0<Re<150) and an area of 
penetrating jets with eddies at low Re and WN/WP (Re<150 and 0.22<WN/WP<0.5).  The 
mappings of HA/WA=1.25 and 1.5 (Appendix B, Fig. 8.3) were similar to graphs for HA/WA=1; 
however, asymmetric layered eddies appeared in the HA/WA=1.5 flow map over 0<Re<500 at all 
WN/WP ratios. As HA/WA was increased to 1.75 (Fig. 2.5D), the area on the map of single eddies 
increased and was independent of Re for WN/WP<0.5. An area of penetrating jets with eddies 
existed for low Re (Re<150) and intermediate WN/WP values (0.5<WN/WP<1).  Asymmetric 
layered eddies dominated over a large range of Re (0<Re<500) at WN/WP>0.4. 
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Figure 2.5: Flow mapping of sidewall aneurysms. (A) Characteristic asymmetric flows in 
sidewall aneurysms: i) Penetrating jets with eddies (Re=5, HA/WA=1, WN/WP=1.5) ii) Eddies 
(Re=300, HA/WA=1, WN/WP=1.5) iii) Layered eddies (Re=500, HA/WA=1.5, WN/WP=0.5). Flow 
mapping in terms of various aneurysm height to width (HA/WA) ratios, Reynolds numbers (Re), 
and neck to parent width (WN/WP) ratios: (B) HA/WA=0.5 (C) HA/WA=1 (D) HA/WA=1.75. 
Dashed lines indicate physiological Re. 
A 
C 
B 
D 
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2.6 Wall Shear Stress Analysis 
The WSS profile and corresponding streamlines are shown in Figure 2.6Ai for 
HA/WA=1.75, Re=400, and WN/WP=1 in a centered aneurysm model.  As HA/WA increased, the 
fraction of the aneurysm arc length that experienced low WSS (<0.01 N/m2) increased (Fig. 
2.6Aii).  The magnitude of the WSS increased with Re and HA/WA despite affecting a smaller 
area.  The maximum WSS reached approximately 2 N/m2 and 23 N/m2 at Re=100 and 400, 
respectively, for HA/WA=1.75.  For constant geometry, the arc length ratio with low WSS 
decreased with increasing Re (Fig. 2.6Aii). 
For offset aneurysms, the WSS profiles were asymmetric. Figure 2.6Bi illustrates the 
WSS profile and streamlines for HA/WA=1.75, Re=400, and WN/WP=1.  The WSS was high 
where the flow impinged upon the aneurysm and decreased significantly along the wall.  The 
maximum WSS for offset aneurysms reached approximately 4.5 N/m2 and 40 N/m2 at Re=100 
and 400, respectively, for HA/WA=1.75, but the increase in low WSS along the aneurysm wall 
was still apparent as HA/WA increased (Fig. 2.6Bii).  We did not observe a significant difference 
in the arc length ratio of low WSS at Re=100 and 400 for HA/WA=0.5, 1, or 1.75.  For 
HA/WA=0.5, the WSS remained above 0.01 N/m2 and thus was not included in the analysis.  
Similarly, sidewall aneurysm WSS profiles were asymmetric but had magnitudes greater than 
0.01 N/m2 for the conditions tested (Re=100, 400 and HA/WA=0.5, 1, and 1.75). The maximum 
WSS for sidewall aneurysms reached approximately 9 N/m2 and 40 N/m2 at Re=100 and 400, 
respectively, for HA/WA=1.75. 
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Figure 2.6: Wall shear stress analysis. (A) Centered aneurysms: i) Streamlines and shear stress  
profile for HA/WA=1.75 at Re=400 and WN/WP=1 ii) Aneurysm arc length ratio with low shear 
stress along aneurysm wall. (B) Offset aneurysms: i) Streamlines and shear stress profile for H-
A/WA=1.75 at Re=400 and WN/WP=1 ii) Aneurysm arc length ratio with low shear stress along 
aneurysm wall. 
 
 
 
A 
B 
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2.7 Discussion 
We analyzed how changes in geometry and Re alter hemodynamic profiles in idealized 
aneurysm geometries and identified transition boundaries where the flow patterns change 
categorically.  These basic flow characterizations may facilitate our understanding of how the 
hemodynamic landscape and WSS affect complex biological processes [11, 93, 99].  Aneurysm 
growth and rupture most likely results from a combination of physical and biological 
phenomena.  For example, changes in flow and WSS have been shown to regulate endothelial 
gene expression [105, 106].  Our systematic mapping and non-dimensional analysis of flow 
patterns as a function of Re, geometric shape factors, and aneurysm location identify 
qualitatively when changes in hemodynamics and WSS may occur. 
Flow patterns similar to those in our analyses have been reported in the literature [90, 
100]. For example, the 2D computational study of Burleson et al. showed an asymmetric eddy 
profile for a sidewall aneurysm with HA/WA=0.925, Re=400, and WN/WP=2 [90].  3D 
hemodynamic studies showed similarities with our flow patterns as well.  Utter and Rossmann 
showed penetrating bifurcating jets with eddies in their analysis of centered aneurysms with 
HA/WA=1 and WN/WP=1 while Hoi et al. found asymmetric eddies in their evaluation of the 
hemodynamics in sidewall aneurysms with HA/WA=1, WN/WP=2.5, and Re=136 [92, 107].  
Thus, we have shown qualitative agreement between our analysis and other reports. 
Unlike other studies that evaluate a limited number of geometries and flow conditions, 
we have identified common flow patterns and transition boundaries for a broad range of 
aneurysms.  Several aneurysm geometries had flow patterns that are independent of changes in 
Re.  Thus, changes in flow velocity or viscosity did not qualitatively affect hemodynamics.  For 
example, Perktold et al. have found that altering Re from 150 to 250 did not significantly affect 
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the flow pattern of penetrating bifurcating jets for offset aneurysms with HA/WA=1 and 
WN/WP=0.825 [7].  These flow patterns corresponded to our flow map in Figure 2.4B.  
However, in some instances, small changes in Re or geometric shape factors can alter the flow 
profile.  Hoi et al. showed that the impingement area increased significantly as the curvature of 
the parent artery increased for lateral aneurysms with HA/WA=1, WN/WP=2.5 and Re=136, 
causing the flow patterns to change from eddies to penetrating jets with eddies [107].  Our 
mapping of the hemodynamic landscape recognizes relationships between aneurysm geometry 
and flow characteristics. 
Identifying transitions between regions of different flow patterns may be important in the 
assessment of treatment of options and predictions of rupture.  For centered aneurysms, we 
observed that for a given Re, the flow profiles evolved from regions of eddies to penetrating 
bifurcating jets with eddies to asymmetric flows as the neck to parent vessel width (WN/WP) ratio 
increased.  Offset aneurysms were dominated by penetrating jets or penetrating jets with eddies.  
Asymmetric flows or layered eddies were characteristic of sidewall aneurysms.  We found that 
centered aneurysms were more affected by changes in geometry and Re than offset or sidewall 
aneurysms.  Aneurysm location, geometry, and Re dictated the presence of transition boundaries 
between distinct flow profiles. 
In addition to flow patterns, WSS profiles were affected by changes in geometry and Re.  
We found that deep aneurysms (HA/WA>1) had large regions of low WSS and a high magnitude 
of high WSS for centered aneurysms (Fig. 2.6A).  Several studies disagree about how the 
magnitude of WSS relates to aneurysm growth and rupture.  In a computational study that 
modeled patient aneurysms, it was shown that the areas of highest WSS were near the neck of 
the aneurysm while the shear stress significantly decreased in the aneurysm dome area [11].  The 
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study concluded that low WSS along the aneurysm wall may facilitate aneurysm growth and 
rupture while high WSS may contribute to the initial development of an aneurysm.  Low WSS 
along the aneurysm wall has been found to correlate to aneurysm growth and rupture in two 
independent, patient-specific computational studies [108, 109]. 
In contrast, some studies have linked high WSS to aneurysm progression [107, 110, 111]. 
Our analysis showed that the appearance of eddies, which correlated to an increase in HA/WA, is 
accompanied by an increase in areas of low WSS along the aneurysm boundary (Figs. 2.3, 2.6).  
This result could be associated with the finding that increases in HA/WA are associated with 
increased rupture [89].  However, it is possible that changes in the magnitude of WSS along the 
aneurysm wall contribute to growth and rupture.  Nonetheless, WSS appears to play a critical 
role in predicting aneurysm wall remodeling and rupture. 
Flow maps, as we have presented here, may benefit from simulations that capture more of 
the physiological conditions present within aneurysms.  The complexities of fluid flow within 
aneurysms are not limited to pulsatile flow, elastic walls, and 3D geometry.  Though studies have 
reported similarities between steady vs. pulsatile, rigid vs. compliant, and 2D vs. 3D simulations, 
future work should accurately and quantitatively validate our assumptions.  Our initial study 
proposes not to quantify exact flow patterns within aneurysms but rather to show that systematic 
and non-dimensional evaluation of aneurysm hemodynamics is useful in relating common 
hemodynamic features and identifying transition boundaries between flow patterns.  Flow maps 
that account for physiological phenomena will improve our understanding of how changes in 
fluid and solid mechanics relate to changes in aneurysm growth and rupture.  Our mapping 
scheme may be useful as an assessment tool and may potentially be used in evaluating aneurysm 
treatment strategies. 
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   We have systematically examined the hemodynamic and WSS profiles of clinically 
relevant, idealized aneurysm geometries for a range of physiological Re.  Our non-dimensional 
analysis may be broadly applied to a wide range of patient-specific aneurysms.  Our findings 
indicated an increase in eddies for bifurcating vessels and layered eddies for sidewall vessels for 
increasing HA/WA and WN/WP.  We demonstrated that small changes in aneurysm geometry or 
Re can result in distinct changes in the hemodynamic and WSS profiles.  This may correlate with 
changes in cellular function that affect vascular biology and structure leading to aneurysm 
growth and rupture. 
 
2.8 Experimental Challenges 
  This aim posed many challenges, including our lack of access to sufficient computing 
power to conduct in depth 3D simulations. We have started collaborating with Prof. Efthimios 
Kaxiras, which will allow us to explore how geometry affects aneurysm flow patterns and wall 
shear stress in 3D. Future experiments will focus on more physiologically relevant aneurysm 
conditions. 
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3 COUPLING HEMODYNAMICS AND BIOLOGICAL RESPONSE IN VITRO 
3.1 Introduction 
The vascular endothelium regulates several biological processes essential for immune 
function, blood flow, and mechanotransduction. Altered hemodynamics is linked to a variety of 
vascular diseases [112-114].  For example, areas of low shear stress or reversing flow have been 
associated with the early stages of atherosclerosis and plaque formation [115, 116]. Shear stress 
has been linked to aneurysm pathophysiology as well [1]. Determining how hemodynamics 
alters endothelial cell function may be essential for evaluating disease states. 
The growth and rupture of cerebral aneurysms may be related to hemodynamics and wall 
shear stress (WSS).  We examined the effect of aneurysm geometry on WSS and the influence of 
reduced WSS on human aortic endothelial cell (HAEC) monolayers within flow channels since 
shear stress is often decreased in cerebral aneurysms compared to normal vessels.  We measured 
gene expression patterns of immune regulatory and extracellular matrix (ECM) components 1 
and 12 h after exposure to 1 dyne/cm2 shear. The ECM proteins collagen I (COLI), collagen IV 
(COLIV), laminin, and fibronectin were visualized by immunostaining HAEC exposed to 0 and 
1 dyne/cm2.  We showed that decreased WSS leads to appreciable changes in expression of many 
genes involved in the inflammatory response and ECM regulation. HAEC regulation of ECM 
proteins was altered upon experiencing shear stress. Understanding the relationship between 
hemodynamics, the inflammatory response, and ECM cues may aid in elucidating the 
pathophysiology of aneurysms. 
We also studied the effects of endothelial cell exposure to pro-inflammatory cytokines 
tumor necrosis factor-α (TNF-α) and interleukin-1α (IL-1α), which are involved in the 
inflammatory response in vivo [117]. We evaluated HAECs and human umbilical vein 
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endothelial cells (HUVECs). We chose to compare both cell lines as HUVECs are a well-
characterized cell line used to study endothelial-leukocyte interactions in vitro [118-120]. 
The rupture of cerebral aneurysms causes stroke, permanent nerve damage, or 
subarachnoid hemorrhage [2]. Previous studies have found that changes in geometry can greatly 
affect the hemodynamics within aneurysms [107, 110, 121]. The physical forces exerted on the 
aneurysm wall may alter the cellular response that could create a vascular microenvironment 
prone to aneurysm growth and rupture. It has been suggested that evaluating the flow patterns 
within clinically relevant aneurysm geometries could help predict possible disease outcomes 
[121]. Indeed, investigating how hemodynamics and the biological responses of the vascular 
endothelial layer are linked could be beneficial for determining aneurysm pathology and 
designing new treatments for cerebral aneurysms. 
The impact of hemodynamics on cellular function is not fully understood. WSS induces 
upregulation of endothelial leukocyte adhesion molecule 1 (E-selectin), intercellular adhesion 
molecule 1 (ICAM1), vascular cell adhesion molecule 1 (VCAM1), thrombomodulin, and ECM 
components including COLIV and laminin [30, 32, 115, 122, 123]. However, the cellular 
response to abrupt changes in WSS has not been assessed thoroughly. 
Vessel structure and compliance are regulated by a balance of ECM synthesis, 
degradation, and remodeling [124]. Degradation of ECM components and remodeling in the 
aneurysm wall characterizes the development of vascular diseases such as atherosclerosis, 
abdominal aortic aneurysm, and cerebral aneurysm growth [26, 125]. Specifically, matrix 
metalloproteinases (MMPs), which are involved in the remodeling of vascular walls such as 
MMP2 and MMP9, have been linked to cerebral aneurysm progression. Additionally, in vivo 
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canine models of aneurysm formation describe the contribution of altered hemodynamics to the 
remodeling of the vascular wall, which include disruption of the internal elastic lamina, loss of 
fibronectin, and reduction of smooth muscle cells [93].  Thus, changes in hemodynamics could 
impact cell function, which may also play a role in aneurysm growth and rupture. 
 Aneurysm geometry has been implicated in rupture [89], and changes in geometry alter 
flow patterns within aneurysms. As a result, the relationship between flow patterns and shear 
stress along the aneurysm wall was analyzed, which may impact vascular biology. In this study, 
we investigated how WSS is affected by flow pattern transitions and determined gene expression 
profiles upon abrupt changes in WSS. The effect of shear stress on ECM components was 
evaluated. Finally, we determined how the expression of cell adhesion molecules (CAMs) on 
ECs was affected by inflammatory cytokines through the evaluation of gene expression and cell 
surface protein expression. 
 
3.2 Methods and Materials 
Computational Model 
We used the COMSOL 3.3 Multiphysics finite-element software to solve the Navier-
Stokes (Eq. 2.2) and continuity (Eq. 2.3) equations assuming incompressible flow of a 
Newtonian fluid. We used typical values for blood density and viscosity (1060 kg/m3 and 3 cP, 
respectively [95, 96]). We assumed 2D, steady (𝜕𝒖
𝜕𝑡
= 0), laminar flow in a rigid-wall model of a 
vessel, and the no slip condition was applied [7, 92, 97]. A fine mesh with a minimum of 7,400 
elements was used to resolve the geometries.  
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We varied the aneurysm neck to parent vessel ratio (aneurysm neck width/parent vessel 
width, WN/WP) while keeping the height to width ratio (aneurysm height/aneurysm width, 
HA/WA) constant.  We varied the Reynolds number (Re), the non-dimensional ratio of inertial to 
viscous forces (Eq. 2.1). Figure 2.1A depicts the aneurysm geometry used in these simulations. 
WSS profiles were calculated along the aneurysm boundary arc length for varying 
WN/WP (0.25-1.5) and Re (50 and 200). These geometries and Re were chosen because of 
observed transitions in flow patterns in these areas (Fig. 2.3B). We present these results through 
the arc length ratio, by which we denote the fraction of the arc length that experienced WSS < 
0.01 N/m2. The results utilize an arc length which is non-dimensionalized by the parent vessel 
width. 
ECM Regulation 
 Confluent monolayers of HAECs (Lonza Walkersville, Walkersville, MD, USA) were 
grown at 37oC with 5% CO2 in a humidified chamber in flow channels made from polydimethyl 
siloxane (PDMS; Sylgard® 184 Silicone Elastomer Kit) in a 10:1 (w/w) base to curing agent ratio 
bonded to glass. Channels were 70 mm long x 7.5 mm wide x 1.6 mm high. Endothelial Cell 
Growth Medium-2 (EGM-2; Lonza, Basel, Switzerland) with either 0 or 2% fetal bovine serum 
(FBS) was flowed into the channels at Re=66 using a peristaltic pump (AC-2110 Perista Pump, 
ATTO Corporation, Tokyo, Japan), causing the cells to experience a WSS of 1 dyne/cm2 for 12 
h. The outlet stream was fed into a 0.22 µm cellulose acetate filter unit (Corning Life Sciences, 
Lowell, MA, USA) to avoid contamination. Cells experiencing no flow were incubated with 
media containing either 0 or 2% FBS for 12 h. Cells were fixed with 4% formaldehyde and 
blocked with 1% bovine serum albumin (BSA) in phosphate buffered saline (PBS). Cells were 
then stained with mouse anti-human COLI or COLIV IgG1 (Sigma-Aldrich, St. Louis, MO, 
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USA) or rabbit anti-human laminin or fibronectin IgG (Sigma-Aldrich). Secondary staining was 
done with goat anti-mouse IgG1 conjugated to fluorescein isothiocyanate (FITC, Caltag 
Laboratories, Burlingame, CA, USA) or goat anti-rabbit IgG conjugated to Texas Red 
(Invitrogen, Carlsbad, CA, USA) followed by a Hoechst 33342 (Invitrogen) nuclear stain. Glass 
coverslips were also incubated with media (0 or 2% FBS) only for 12 h and staining as 
described. 
Gene Expression 
 Cells were sheared in the manner described above for 4 h at 1 dyne/cm2 with media 
containing 2% FBS. Total RNA was isolated from cells using a Qiagen RNeasy Mini Kit 
following the manufacturer’s procedures (Qiagen, Valencia, CA, USA).  The cells were either 
lysed immediately after flow or lysed after 1 or 12 h of static incubation after flow. The control 
cell population experienced no flow. Quantitative reverse transcriptase polymerase chain 
reaction (qRT-PCR) was performed on a 7300 real-time PCR system using the Taqman method 
(Applied Biosystems, Carlsbad, CA, USA). We evaluated the regulation of a variety of genes 
involved in tissue injury and remodeling: E-selectin, ICAM1, VCAM1, platelet endothelial cell 
adhesion molecule 1 (PECAM1), type I collagen (COLI), COLIV, MMP2, and MMP9. 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as the endogenous control. All 
primers were obtained from Applied Biosystems. 
HAECs or HUVECs were seeded in 12 well plates and grown to confluence in EGM-2 
media with 2% FBS. Cells were treated with 1, 10, or 25 ng/mL of TNF-α (Sigma Aldrich) or 
IL-1α (R&D Systems, Minneapolis, MN, USA) at 1, 5, or 10 ng/mL for 2, 4, 6, 12, or 24 h. 
Experiments were done in triplicate, and controls were performed with no cytokine treatment. 
Again, cells were lysed, RNA was extracted and converted to cDNA, and qRT-PCR was 
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performed. An endogenous control of GAPDH was used, and evauations were done in triplicate. 
Relative expression levels of E-selectin and VCAM1 were assessed. 
Flow Cytometry 
VCAM1 and E-selectin expression by ECs was evaluated by flow cytometry after 1, 6, 
12, and 24 h incubations with either IL-1α (5 ng/mL) or TNF-α (20 ng/mL) [85]. Quantification 
of the density of molecules on the surface was done using QuantumTM Simply Cellular® 
microbeads. After ECs were activated with IL-1α or TNF-α, 106 cells were collected from a 6-
well plate, spun down, and resuspended with ice cold 1% BSA. ECs were rinsed 3 times through 
suspension-spin cycles and blocked with 1% BSA in PBS for 30 min in an ice bath. ECs were 
incubated with mouse anti-human VCAM1 and sheep anti-human E-selectin monoclonal 
antibodies (1 mL, 10 ng/mL) for 30 min in an ice bath. After rinsing with 1% BSA three times to 
remove free antibodies, ECs were stained with FITC-conjugated goat anti-mouse and 
tetramethylrhodamine isothiocyanate (TRITC)-conjugated rabbit anti-sheep secondary antibodies 
for 30 min in an ice bath. ECs were finally rinsed with 1% BSA three times, resuspended in PBS, 
and analyzed by flow cytometry. 
 
3.3 Hemodynamic Analysis 
 Three characteristic flow patterns were found upon altering aneurysm geometry (Fig. 
2.2): eddies, penetrating bifurcating jets with eddies, and asymmetric bifurcating jets. Fig. 2.3B 
shows the characteristic flow map based on Re and WN/WP ratio at a constant HA/WA=1. The 
presence of eddies was shown at low Re (<100) and low WN/WP (<0.5). Penetrating bifurcating 
jets with eddies were found between 100<Re<300 for WN/WP<0.5 and at low Re for all other 
WN/WP ratios.  Asymmetric bifurcating jets dominated at large Re and WN/WP ratios.   
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The shear stress along the aneurysm arc length was analyzed over areas where flow 
pattern transitions occurred. The flow patterns were found to transition from eddies to 
penetrating bifurcating jets with eddies to asymmetric bifurcating jets at Re=50 and from 
penetrating bifurcating jets with eddies to asymmetric bifurcating jets at Re=200 upon increasing 
WN/WP. As the WN/WP ratioincreased at a constant HA/WA=1, representing a widening of the 
aneurysm, the percentage of the aneurysm arc length that experienced low WSS decreased (Fig. 
3.1). In addition, as Re increased from 50 to 200, the arc length that experienced low WSS 
decreased. Aneurysms with the lowest Re and WN/WP ratios had the highest incidence of low 
WSS along the arc length. 
 
 
 
 
 
 
 
 
Figure 3.1: Low wall shear stress analysis. HA/WA=1 and varying Re and WN/WP. 
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3.4 Modulating Endothelial Cell Gene Expression with Shear Stress 
We showed how changes in shear stress can alter the expression of HAEC inflammatory 
(Fig. 3.2A) and ECM regulative (Fig. 3.2B) genes. Appreciable differences in gene expression 
were found when cells were lysed immediately after steady shear or waiting 1 or 12 h. The 
expression of E-selectin and ICAM1 decreased significantly after 12 h, while VCAM1 showed a 
decrease in expression after waiting only 1 h (Fig. 3.2A). The expression of PECAM1 remained 
constant. Although the shear stress of 1 dyne/cm2 was well below the physiological value of 
approximately 36 dyne/cm2 in cerebral vessels [11], E-selectin was upregulated by 
approximately 20 times compared to the no flow condition and 40 times greater than waiting 12 
h after shear. COLIV increased in expression after 1 h while decreasing again after 12 h, and 
MMP2 increased in expression after 1 h and remained high after 12 h (Fig. 3.2B). The 
expression of COLI decreased slightly after 1 h, and MMP9 levels remained relatively constant. 
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Figure 3.2: Gene expression profiles of ECs upon changing shear stress. (A) Inflammatory 
and (B) ECM gene expression from qRT-PCR on HAEC after 4 h of shear stress at 1 dyne/cm2. 
Solid bars correspond to cells lysed immediately after flow, diagonal lines to lysing cells after 1 
h, and white bars to lysing cells 12 h after flow. Normalized fold change represents the 
proportional change in expression compared to the no flow condition. Gene abbreviations: E-
selectin, ICAM1, PECAM1, VCAM1, COLI, COLIV, MMP2, and MMP9. 
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3.5 The Effect of Shear Stress on ECM Regulation 
 We have evaluated the HAEC expression of the ECM components COLI, COLIV, 
laminin, and fibronectin after being exposed to shear stress (Fig. 3.3). After 12 h of steady shear 
with media containing serum, cell morphology was elongated compared to the cells experiencing 
no flow. COLI was expressed highly after flow, while the fibronectin network appeared more 
extended along the cell membrane. Laminin expression increased along the cell membrane after 
shearing compared to the static condition where it was concentrated around the nucleus. COLIV 
was expressed across the membrane before and after flow. 
 
ECM 
Components 
Flow No Flow No Flow 
No Serum 
COLI (green) 
Fibronectin (red) 
   
COLIV (green) 
Laminin (red) 
   
 
Figure 3.3: Immunofluorescence staining of HAECs after shear. HAECs stained for COLI, 
COLIV, fibronectin, and laminin after 12 h shear at 1 dyne/cm2 or no shear. Nuclear stain is 
shown in blue. Scale bar is 25 µm. 
48 
 
The ECM components of the cells incubated without serum under no shear were 
comparable to the serum condition: strong fibronectin and faint COLI expression across the cell 
membrane, concentrated laminin around the nucleus, and diffuse COLIV across the membrane. 
Control glass coverslips incubated only with media exhibited no ECM staining as expected. 
 
3.6 VCAM1 and E-selectin Expression under Inflammatory Conditions 
   In line with previous studies looking at the effects of infllammatory cytokines in vitro, we 
evaluated the effects of stimulation of ECs with 1-10 ng/mL and 1-25 ng/mL for IL-1α and TNF-
α, respectively [86, 126-129].  The results are shown in Figures 3.4-3.6 below. In HAECs, 
expression of VCAM1, ICAM1, E-selectin was maximized upon treatment with 10 ng/mL TNF-
α for 4 h. The highest upregulation of VCAM1, ICAM1, and E-selectin on HUVECs occurred at 
25 ng/mL and 24 h of TNF-α stimulation. Stimulation with 5 ng/mL IL-1α for 6 h provided the 
highest upregulation of all molecules. HUVEC gene expression levels exceeded HAEC levels in 
magnitude. Because ICAM1 had the lowest expression levels for all cell lines and treatments, we 
proceeded in quantifying only VCAM1 and E-selectin surface markers in the flow cytometry 
experiments. 
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Figure 3.4: HAEC gene expression profiles after exposure to TNF-α. Profiles for (A) 
VCAM1, (B), E-selectin, and (C) ICAM1 after treatment with 1-25 ng/mL TNF-α for 4-24 h. 
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Figure 3.5: HUVEC gene expression profiles after exposure to TNF-α. Profiles for (A) 
VCAM1, (B), E-selectin, and (C) ICAM1 after treatment with 1-25 ng/mL TNF-α for 4-24 h. 
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Figure 3.6: HUVEC gene expression profiles after exposure to IL-1α. Profiles for (A) 
VCAM1, (B), E-selectin, and (C) ICAM1 after treatment with 1-10 ng/mL IL-1α for 2-24 h. 
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Surface expression of VCAM1 and E-selectin on HUVECs was similar after treatment 
with either IL-1α and TNF-α (Fig. 3.7) [85]. VCAM1 expression increased and reached a 
saturation point after 24 h while E-selectin expression peaked at 6 h and subsequently decreased 
over time. 
 
 
 
 
 
 
 
 
Figure 3.7: Expression of VCAM1 and E-selectin on TNF-α and IL-1α activated HUVECs. 
Expression of VCAM1 (A) and E-selectin (B) is determined using flow cytometry as a function 
of time. Error reported is standard error with n = 3. 
 
3.7 Discussion 
We have shown the effect of abrupt decreases in WSS on gene expression and ECM 
deposition. Changes in flow patterns within aneurysm geometries may lead to considerable 
biological changes regarding shear stress, gene expression, and ECM surface expression. We 
sheared HAECs within flow channels and treated HAECs and HUVECs with inflammatory 
cytokines to understand how these factors would affect gene expression. We used flow to 
determine the effect of constant shear on the ECM. 
A B 
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We examined the effect of flow pattern transitions within different aneurysm geometries 
on shear stress along the aneurysm wall (Fig. 3.1). We determined that decreasing the WN/WP, 
which narrows an aneurysm, led to increasing areas of low WSS on the arc length. WSS has 
been linked to aneurysm pathophysiology, but its direct role is unclear [1].  For example, low 
magnitude WSS has been linked to aneurysm growth and rupture [11, 108, 109]. However, high 
shear has been correlated to aneurysm growth [107, 110, 111]. Though there are competing 
theories about how aneurysms rupture, shear stress most likely plays a part in aneurysm 
progression.  
We assessed effect of decreasing WSS on HAEC gene expression (Fig. 3.2). WSS was 
abruptly decreased to mimic the aneurysm environment, where the growth of an aneurysm leads 
to decreased flow and WSS. Physiological shear stress in arteries can vary between 
approximately 10-20 dyne/cm2 [130]. The WSS within aneurysms is variable both spatially and 
in terms of magnitude; WSS in aneurysms has been estimated in the range of 1-35 dyne/cm2 
[11]. Changes in VCAM1, ICAM1, COLIV, and MMP2 have previously been implicated in 
aneurysm pathophysiology [69, 131-133]. Even at the low WSS of 1 dyne/cm2, significant 
changes are observed in the regulation of gene expression in HAECs. E-selectin and ICAM1, 
adhesion molecules involved in the inflammatory response, increased after 1 h of static 
incubation following 4 h shear at 1 dyne/cm2. Expression of E-selectin and ICAM1 have been 
found to increase in the cerebrospinal fluid after aneurysm rupture [134]. Although VCAM1 
decreased after static incubation in our study, in vivo studies suggest that higher levels of 
VCAM1 are found in aneurysms compared to normal vessels [69, 134]. This discrepancy could 
be due to the presence of immunological factors and cells recruited in vivo. Nevertheless, the 
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inflammatory response is significant in the progression of aneurysms, and decreases in shear may 
be involved in creating an aneurysm environment susceptible to rupture. 
With regards to ECM regulatory gene expression, stopping flow after 4 h shear at 1 
dyne/cm2 for 1 or 12 h decreased COLI expression. This correlates with the reduction of COLI 
levels observed in cerebral aneurysms [135]. After decreasing shear for 1 h, expression of 
COLIV increased; this pattern has similarly been observed in human cerebral aneurysms after 
surgery [136]. An increase in COLIV may cause vessels to increase in stiffness and could lead to 
higher susceptibility of rupture [137]. MMP2 levels increased in comparison to the gene 
expression immediately after shear, which relates to previous findings of increased levels of 
MMP2 in aneurysms [133]. Expression of MMP9 did not increase after decreasing shear stress in 
our study. This might be explained by the fact that the in vivo response requires immune cells to 
release MMP9 into the aneurysm cavity [26]; such cells were not present in our experiments. 
Other studies have examined the effect of altered or disturbed flow on EC gene 
expression [106, 138]. For example, a step-flow chamber was used to probe the effects of 
disturbed flow on bovine aortic ECs [139]. This study showed that disturbed flow at 12 dyne/cm2 
caused sustained activation of a transcription factor involved in biosynthesis of cholesterol, sterol 
regulatory element binding protein, while steady, laminar shearing produced a transient response.  
These studies suggest that altered flow, and consequently altered WSS, within aneurysms can 
lead to significant biological changes. 
We additionally evaluated how the presence or absence of WSS can affect ECM 
regulation (Fig. 3.3). Aneurysm occurrence and growth has been shown to be affected by matrix 
remodeling events that alter or degrade the ECM [133]. COLI expression increased in HAECs 
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after 12 h sustained shear compared to the cells experiencing no flow, which did not correlate 
with the decreased biosynthesis of COLI observed in our altered shear experiment or in vivo 
studies [135]. Fibronectin, which has been implicated in aneurysm repair, was found to change 
expression patterns by stretching with the elongated cell after the cell experienced shear stress 
[140]. Cells starved from serum after 12 h shear did not remain fully attached to the glass 
substrate and did not retain an elongated morphology. The differences found in ECM expression 
after constant shearing compared to conditions of altered shear suggest that the changes in WSS 
experienced within aneurysms could have distinct effects on cellular gene and protein 
expression. It is also possible that gene expression of ECM components does not correlate with 
ECM regulation. Further experiments exploring the differences between gene expression and 
protein regulation would be beneficial for understanding aneurysm remodeling events. 
We have shown how decreasing shear stress affects EC gene expression and ECM 
regulation. A decrease in WSS led to considerable changes in inflammatory and ECM regulatory 
gene expression, which correlates with in vivo studies. ECM regulation was altered by low shear 
stress. The interplay between hemodynamics, shear, and biological response may dictate 
aneurysm pathophysiology. This work demonstrates how aneurysm growth, which reflects 
modifications in shear stress along the aneurysm wall, can potentially lead to appreciable 
biological changes. 
The cytokines IL-1α and TNF-α play an important role in the progression of 
inflammation and injury. Patterson et al. suggest that TNF-α activation provides a close 
representation of CAM changes associated with dysfunctional endothelium [141], and TNF-α 
has been shown to increase endothelial permeability and cause cytoskeletal reorganization [142]. 
IL-1α increases expression of CAMs, activates EC and smooth muscle cell proliferation, 
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activates macrophage infiltration, increases vascular permeability, and contributes to EC 
dysfunction by stimulating the creation of deleterious reactive oxygen and nitrogen species 
[143]. We have shown the influence of the concentration and treatment time of these cytokines 
on CAM gene and protein expression. 
 There are limitations associated with this aim. First, we chose to change shear stress 
temporally rather than spatially. In vivo, aneurysm growth causes spatial changes in shear stress 
due to changes in hemodynamics. We could have more closely modeled the aneurysm 
environment by shearing ECs in a construct with angled edges to create spatial changes in shear. 
Nonetheless, we found that an abrupt, slight change in shear from 1 to 0 dyne/cm2 causes 
discernible differences in gene expression. We do not claim that this experimental set-up 
recapitulates the aneurysm environment; however, these results have implications for aneurysm 
pathophysiology since we have shown the importance of changing shear with respect to gene 
expression. In addition, we treated ECs with inflammatory cytokines to recapitulate an acute 
immune response. ECs within aneurysms in vivo most likely exhibit varying expression profiles 
from what is shown in vitro. However, we will use the information gained in this aim as a basic 
model for targeting ECs with biomaterials. Future studies should take these factors into account 
for a more realistic model system. 
 The results from this aim have determined how we proceeded in stimulating ECs in 
future experiments to design biomaterials for EC adhesion. Because the aneurysm environment 
is considered inflammatory and gene expression is higher on ECs exposed to inflammatory 
cytokines (Figs. 3.4-3.7) rather than those exposed to shear, we will continue to activate ECs by 
simulating inflammatory events. We will use HUVECs in all further experiments due to their 
higher levels of gene expression as compared to HAECs, which would allow for easier targeting 
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of inflamed cells. IL-1α will be used as the main agent for simulating inflammation. This is due 
to the fact that the qRT-PCR results derived after IL-1α stimulation followed our flow cytometry 
results, indicating that gene expression and cell surface protein expression were similar. Since 
expression of VCAM1 and E-selectin were maximized with 5 ng/mL IL-1α treatment after 6 h at 
much higher magnitudes than ICAM1, we will target only VCAM1 and E-selectin using this 
activation protocol for all subsequent experiments. 
 
3.8 Experimental Challenges 
  Completing this section posed many experimental challenges, especially in regards to the 
shear stress experiments. During the flow experiments, contamination within the channels was a 
major obstacle. Despite use of extensive sterilization procedures, including autoclaving, UV 
sterilization, ethanol sterilization, and filtration, contamination occurred at a high frequency. 
However, we were able to complete enough experiments without contamination for evaluation of 
gene expression. This is one reason we shifted our focus toward assessing inflammatory 
environments. To combat contamination in flow experiments in the future, we may attempt to 
use all glass channels rather than PDMS/glass constructs, and we may consider using tubing that 
is more resistant to contamination. 
  There were further limitations in the magnitude of shear stress that could be achieved 
with our flow pump, which is why we only evaluated the effects of a shear stress of 1 dyne/cm2. 
We have since acquired a flow apparatus capable of higher flow rates and may explore higher 
shear stresses in future experiments. In addition, we may consider using microfluidic channels to 
achieve increased shear stresses. 
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4 POLYVINYL ALCOHOL HYDROGELS 
4.1 Introduction 
Adhesion is an important regulator of cell proliferation, migration, apoptosis, and 
differentiation [144]. Previous research has demonstrated that adhesion is dependent on matrix 
chemistry and stiffness. For example, cell adhesion and migration is influenced by varying the 
density of cell adhesion peptides on surfaces [145], and cell spreading and density is regulated by 
material stiffness [146-148]. Matrix stiffness is also observed to direct human mesenchymal stem 
cell differentiation toward neurogenic, myogenic, or osteogenic commitment [149]. Previous 
reports have tailored adhesion by adjusting a single parameter. In contrast, biology utilizes 
multiple cues to regulate cell behavior. 
Leukocyte-EC adhesion is regulated via multiple interactions between cell adhesion 
molecules (CAMs), such as vascular cell adhesion molecule-1 (VCAM1) and endothelial 
leukocyte adhesion molecule-1 (E-selectin), and their binding ligands. Their role in leukocyte 
rolling, adhesion, and transmigration has been elucidated [150]. Antibodies that target CAMs 
have been used to modify drug delivery vehicles [151] or surfaces [152] to target inflamed ECs 
and cancer cells, respectively.  
We have recently exploited the use of multiple CAMs on drug delivery vehicles that 
exhibited synergistic adhesion in targeted drug delivery [85-87]. Increased vehicle-cell binding 
was achieved at optimal anti-VCAM1:anti-E-selectin ratios that complemented cytokine-
activated EC surface expression. Cytokine-activated CAM expression is essential in harnessing 
the immune response; dysfunction of this response can lead to diseased states, such as 
atherosclerosis [153], ischemic cerebrovascular disease [154], cerebral aneurysms [69], and 
rheumatoid arthritis [155]. 
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We hypothesized that cell adhesion could be engineered via modification of hydrogel 
surface chemistry and elasticity. Polyvinyl alcohol (PVA) was chosen because it is non-
degradable, non-adhesive, and can easily be modified [156]. We mimicked adhesive interactions 
between cells via the presentation of antibodies that bind VCAM1 and E-selectin on PVA 
hydrogels. We additionally investigated the effect of surface elasticity on cell adhesion by 
varying the methacrylate content of PVA gels. Understanding how to engineer cell adhesion is a 
fundamental problem in the development of materials for vascular remodeling.  
 
4.2 Methods and Materials 
Materials 
PVA (MW 31 kDa, 88% hydrolyzed), dimethyl sulfoxide (DMSO), 2-
isocyanoethylmethacrylate (2-ICEMA), 2,6-di-tert-butyl-4-methylphenol (DTBMP), 4-
aminobutyraldehyde diethyl acetal (4-ABA), hydrochloric acid (HCl), ammonium hydroxide 
(NH4OH), N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC), N-
hydroxysulfosuccinimide (sulfo-NHS), 2-(N-morpholino)ethanesulfonic acid hydrate (MES), 
and sodium chloride (NaCl) were purchased from Sigma Aldrich (St. Louis, MO). Irgacure 2959 
was purchased from Ciba Specialty Chemicals (Basel, Switzerland). Deuterium oxide (D2O) was 
purchased from Cambridge Isotope Laboratories (Andover, MA). Hank’s Balanced Salt Solution 
(HBSS) and phosphate buffered saline (PBS) were purchased from Invitrogen (Carlsbad, CA).  
Methacrylated, Aminated PVA Synthesis 
PVA was dissolved in DMSO in a 20% w/v solution at 60oC [157]. The solution was 
purged with N2 (g) for 30 min. 1, 2, 5, or 10 mol% of 2-ICEMA was added dropwise. 1% 
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DTBMP was added to inhibit polymerization of methacrylates. The reaction was kept at 60oC for 
4 h. The methacrylated PVA was precipitated in acetone and collected and dried under vacuum. 
Methacrylated PVA was aminated using a method previously described [156, 158]. 
Briefly, a 12% w/v solution of methacrylated PVA was dissolved in water at 40oC. 4-ABA was 
added dropwise to a final concentration of 10 mol% for all formulations. HCl was then added 
dropwise to the solution to bring the pH down below 1, and the reaction was continued for 30 
min. The pH was then increased rapidly to 8.0 with NH4OH, and the final solution was dialyzed 
(MWCO 2000) and lyophilized. 
1H nuclear magnetic resonance (NMR) spectroscopy was performed to confirm the 
successful conjugation of methacrylate and amine groups to the PVA backbone. Specifically, 
samples were dissolved in D2O and spectra were obtained using a Varian M300 Spectrometer. 
Hydrogel Fabrication  
Aminated, methacrylated PVA solutions were made at 10-30% w/v in water with 0.75% 
Irgacure2959 photoinitiator. Solutions were exposed to UV light (21.7 mW/cm2, 365 nm) for 90 
sec, resulting in hydrogels. Hydrogels were synthesized either in Teflon molds (10 mm × 1 mm 
× 30 mm) for use in mechanical studies or in well plates and then cut to an appropriate size using 
a cork borer for use in cell studies. 
Mechanical Properties 
The Young’s moduli of various hydrogel formulations were determined using an Instron 
BioPuls machine (Instron, Norwood, MA). Hydrogels (10 mm × 1 mm × 30 mm) were extended 
at a rate of 1 mm/min at room temperature immediately after polymerization. Swelling properties 
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were evaluated as well. Hydrogels were swollen in HBSS to equilibrium. Mass swelling ratios 
(Q) were calculated by Q = WS / WD, where WS and WD are the masses of the swollen and dry 
hydrogels, respectively. 
Cell Culture 
Human umbilical vein endothelial cells (Lonza, Walkersville, MD) were cultured in 
Endothelial Cell Growth Medium-2 (EGM-2; Lonza). ECs were maintained at 37oC with 5% 
CO2 in a humidified incubator and grown to confluence before seeding onto hydrogels or 12 well 
plates for gene expression studies. All hydrogel formulations used with cells were 20% w/v 
solutions of the precursor methacrylated and aminated PVA. 
Covalent Surface Modification of Hydrogels  
Primary monoclonal mouse anti-human antibodies (R&D Systems, Minneapolis, MN) 
were activated for conjugation to the amine group on synthesized precursor hydrogels using 2 
mM EDC and 5 mM sulfo-NHS in 50 mM MES buffer (pH 6.0, 0.5 M NaCl) for 1 h at room 
temperature [159, 160]. An arginine-glycine-aspartic acid (RGD)-containing peptide (arginine-
glycine-aspartic acid-serine, Tocris Bioscience, Ellisville, MO), anti-E-selectin (R&D Systems) 
antibody only, anti-VCAM1 (R&D Systems) antibody only, or a 1:1 ratio of anti-VCAM1:anti-
E-selectin were added at a total of 0.5 mg antibody/g amine group on the PVA backbone to the 
EDC/sulfo-NHS solution [161]. Hydrogels were added to the solution and allowed to react at 4ºC 
overnight. Gels were rinsed with PBS before use to remove excess reactants. 
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Cell Staining 
ECs were activated for 6 h with 5 ng/mL IL-1α and then seeded onto PVA-2 gels (20% 
w/v). After a 24 h incubation, cells were fixed in cold acetone for 5 min at -20oC. Nuclear and F-
actin stains were performed by concurrent addition of 0.2 µg/mL 4’,6-diamidino-2-phenylindole 
dihydrochloride (DAPI; Millipore, Billerica, MA) and 0.33 µM Alexa Fluor 546 phalloidin 
(Invitrogen) to cells for 1 h at room temperature. Fluorescent images were acquired using 
confocal microscopy (Zeiss LSM 510 META). 
Centrifugation Assay 
Adhesion of cells onto hydrogels was assessed using a centrifugation assay adapted from 
previously described methods [162-164]. Gels were seeded with 0.5 × 106 activated ECs per gel 
for 24 h. Gels undergoing centrifugation were placed in 24 well plates filled completely with 
media in order to avoid the possibly deleterious effects of air bubble formation on cell retention. 
Plates were sealed with Titer-Top Plate Sealant (Electron Microscopy Sciences, Hatfield, PA), 
inverted, and centrifuged at 300 × g for 10 min at 4oC. Hydrogels in plates of identical set-up that 
were inverted at 4oC but not centrifuged were used as controls for all conditions. Following 
centrifugation or inversion, cells were rinsed once with PBS and trypsinized. A Z2 Coulter 
counter (Beckman Coulter, Brea, CA) was used to determine the number of cells adhered to gels 
after either centrifugation or inversion. A cell retention ratio was calculated as the total number 
of cells remaining after centrifugation divided by the number of cells retained after inversion. 
Statistical significance between samples was determined by two-way ANOVA analysis. 
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4.3 Modification of the PVA Backbone 
In this study, we investigated cell adhesion as a function of surface stiffness and 
chemistry. We synthesized PVA hydrogels with increasing percentages of methacrylation. This 
generated a series of hydrogels with differing mechanical properties. Methacrylated PVA was 
subsequently functionalized with an amine moiety for conjugation of antibodies. The 
nomenclature we used for each PVA formulation is as follows: 1 mol% methacrylation is 
designated as PVA-1, 2 mol% is PVA-2, 5 mol% is PVA-5, and 10 mol% is PVA-10. PVA 
hydrogels presenting three ratios of antibodies, either 1:0, 1:1, or 0:1 anti-VCAM1:anti-E-
selectin, were used to study cell adhesion strength. EC binding to functionalized PVA hydrogels 
was quantified using a centrifugation assay and compared to unmodified, aminated PVA and 
RGD-modified PVA. 
Methacrylated, Aminated PVA Synthesis 
Figure 4.1 depicts the chemical reaction scheme for synthesizing methacrylated, 
aminated PVA. Representative 1H NMR spectra for unmodified, methacrylated, and aminated 
PVA are shown in Figures 4.2-4.6. Peaks at chemical shifts of 5.6-6 ppm (vinyl) and 2.8 ppm 
(amine) confirmed successful methacrylation and amination, respectively. Table 4.1 describes 
the efficiency of methacrylation and amination for the four PVA formulations. This was 
calculated from the ratio of vinyl or amine peaks to the –CH and –CH2 groups in the NMR 
spectra as determined by the area under the curve (AUC). 
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Figure 4.1: Reaction scheme for methacrylation (1) and amination (2) of polyvinyl alcohol.  
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Figure 4.2: 1H NMR spectrum of unmodified PVA.  
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Figure 4.3: 1H NMR spectrum of PVA-1. (A) Methacrylated and (B) methacrylated and 
aminated PVA-1. 
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Figure 4.4: 1H NMR spectrum of PVA-2. (A) Methacrylated and (B) methacrylated and 
aminated PVA-2. 
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Figure 4.5: 1H NMR spectrum of PVA-5. (A) Methacrylated and (B) methacrylated and 
aminated PVA-5. 
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Figure 4.6: 1H NMR spectrum of PVA-10. (A) Methacrylated and (B) methacrylated and 
aminated PVA-10. 
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Table 4.1: Functionalization of PVA backbone as determined by 1H-NMR 
 Target 
Methacrylation 
(mol%) 
Measured 
Methacrylation 
(mol%) 
Target 
Amination 
(mol%) 
Measured 
Amination 
(mol%) 
PVA-1 1 0.68 10 4.3 
PVA-2 2 1.15 10 4.6 
PVA-5 5 1.73 10 4.6 
PVA-10 10 3.41 10 4.4 
 
4.4 Mechanical Properties of PVA Hydrogels 
Methacrylate group concentration was altered to vary the elastic and swelling properties 
of synthesized gels. Crosslinking occurred with the formation of poly (methacrylate) chains that 
connect two or more PVA chains. A schematic of this process is shown in Fig. 4.7. The distance 
between crosslinks is dependent on the degree of substitution of the PVA chain. Young’s moduli 
varied between 130 and 720 kPa for gels synthesized from a 10% w/v PVA-1 polymer solution 
and 30% w/v PVA-10 polymer solution, respectively (Fig. 4.8A). Young’s moduli increased 
with increasing percentage of methacrylation or weight percent of PVA in polymer solutions. 
Mass swelling ratios reflected the extent of crosslinking of the gels (Fig. 4.8B); swelling ratios 
increased as the amount of methacrylate groups or weight percent of PVA decreased. 
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Figure 4.7: Schematic of PVA crosslinking.  
PVA backbone 
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Figure 4.8: Characterization of PVA hydrogel mechanical properties. The Young’s modulus 
(A) and mass swelling ratio (B) of PVA hydrogels is dependent on the degree of methacrylation 
and the weight percent of PVA. Error bars reported are standard error. 
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4.5 Functionalizing PVA Hydrogel Surfaces 
ECs temporally upregulate VCAM1 and E-selectin in well-characterized patterns. We 
confirmed increased expression of VCAM1 and E-selectin in ECs exposed to 1, 5, or 10 ng/mL 
IL-1α for 2, 6, or 24 h (Fig. 3.6). The results were similar to those in documented reports of 
cytokine activated EC expression [80], including our previous publication that correlates gene 
expression with surface CAM presentation [85]. EC stimulation with 5 ng/mL IL-1α for 6 h 
resulted in the highest upregulation of both E-selectin and VCAM1. ECs were activated to 
maximize cell surface expression prior to being seeded on functionalized PVA hydrogels. 
The relative cell adhesion abilities of PVA hydrogels with varying mechanical and 
chemical properties were investigated. Hydrogels (20% w/v) exhibiting sequentially increasing 
Young’s moduli and decreasing mass swelling ratios were prepared from PVA-2, PVA-5, and 
PVA-10 solutions. Adhesion onto PVA-1 hydrogels was not evaluated due to the fragility of 
these hydrogels upon handling. Cell adhesion onto hydrogels modified with one of three ratios of 
anti-VCAM1:anti-E-selectin was tested and compared to that on unmodified, aminated PVA and 
RGD-modified PVA. Activated ECs were seeded onto hydrogels for 24 h. More ECs adhered to 
functionalized PVA hydrogels than to unmodified, aminated PVA hydrogels (Fig. 4.9). Gels 
modified with a 1:1 ratio of anti-VCAM1:anti-E-selectin had the highest cell density on their 
surface 24 h post-seeding (2 × 105 cells/cm2). Surface cell densities (1 × 105 cells/cm2) were 
comparable between gels presenting RGD, anti-E-selectin, or anti-VCAM1. Surface cell 
spreading was not observed on unmodified, aminated PVA hydrogels; cell spreading was 
qualitatively lower on hydrogels modified with anti-VCAM1 than on hydrogels modified with 
RGD, anti-E-selectin, or 1:1 anti-VCAM1:anti-E-selectin (Fig. 4.10). 
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Figure 4.9: Confocal microscopy images of activated ECs on hydrogels. ECs are activated for 
5 ng/mL IL-1α treatment for 6 h and seeded onto PVA-2 hydrogels (20% w/v PVA) for 24 h and 
stained with F-actin (red) and nuclear stains (blue). Scale bar is 50 µm. 
 
 
 
 
Figure 4.10: Morphology of ECs seeded onto hydrogels. ECs are stained with phalloidin (red) 
and DAPI (blue). Scale bar is 25 µm. 
 
4.6 Cooperative Binding 
Strength of cell adhesion onto hydrogel surfaces was examined via a centrifugation assay. 
We determined the cell retention ratio by dividing the number of cells adhered after gel 
centrifugation at 300 × g for 10 min by the number of cells adhered after gel inversion (1 × g) for 
10 min. Cell adhesion onto PVA hydrogels modified with a 1:1 ratio of anti-VCAM1:anti-E-
selectin was higher than on unmodified hydrogels and those modified with RGD, anti-E-selectin, 
or anti-VCAM1. No significant differences in adhesion onto PVA hydrogels with varying 
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mechanical properties (Young’s moduli ranging from 170-450 kPa) were identified. However, 
differences in adhesion between the antibody-functionalized hydrogels were most pronounced on 
hydrogels with greater stiffness (PVA-10 vs. PVA-2) (Fig. 4.11). 
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Figure 4.11: Synergistic binding of ECs on dual functionalized PVA hydrogels. Retention of 
ECs stimulated with IL-1α (5 ng/mL for 6 hr) seeded onto antibody-modified hydrogels. All 
PVA hydrogels tested were synthesized from 20% w/v PVA solutions. Cell retention ratio is 
defined as ratio of cells remaining on gels after centrifugation at 300 × g divided by cells 
retained on non-centrifuged samples. Error bars are reported as standard error. Statistical 
significance was calculated using a two-way ANOVA analysis with *p < 0.05, **p < 0.01, and 
***p < 0.001. 
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4.7 Discussion 
We synthesized a series of PVA hydrogels with different mechanical and chemical 
properties. We modified hydrogels with either antibodies against cell adhesion molecules 
upregulated on inflamed endothelium or RGD, a peptide that binds the α5β1 integrin domain 
[165]. Our interest in cell adhesion molecules is derived from the fact that these molecules are 
regulated by cytokine-activation in a temporal and reproducible manner [80] and are localized 
within lipid rafts on the cell surface [166]. Mimicking cell-cell interactions by modifying 
hydrogels with antibodies against CAMs may allow for the engineering of the strength of cell 
adhesion onto polymeric materials. 
Cell adhesion molecules participate in leukocyte-EC interactions while integrins mediate 
cell-matrix interactions. RGD signaling involves the FAK pathway [167] whereas VCAM1 and 
E-selectin signaling are mediated by the Rac pathway [168] and activation of the ERK1/2 
pathway [169], respectively. Rac and ERK 1/2 are downstream of FAK; these pathways regulate 
various cellular processes, including adhesion, migration, and actin polymerization [170]. Thus, 
directing adhesion through cell adhesion molecules is similar to the use of RGD. However, our 
approach is unique because we can tune adhesion based on the molecular density and 
organization of anti-VCAM1 and anti-E-selectin presented on hydrogel surfaces. 
The mechanical properties of our synthesized PVA hydrogels ranged from 130 to 720 
kPa. This range reflected the Young’s moduli exhibited by soft tissues, including thoracic aorta 
and femoral arteries (126-433 kPa [171]) and articular cartilage (500-1000 kPa [172]). Our 
hydrogels were stiffer than collagen (0.1-0.4 kPa [173])  and conventional alginate hydrogels 
(13-45 kPa, 0.21 g/mL calcium sulfate (CaSO4) [174]) but were softer than hydroxyethyl 
methacrylate (HEMA) gels (1600 kPa, 3 mol% tetraethylene glycol dimethacrylate (TEGDMA) 
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[175]). Additionally, the mechanical properties of our gels fell within the range of previously 
described methacrylated PVA hydrogels, which spanned from 55-838 kPa [156, 157, 176]. Cell 
adhesion was not significantly altered within the range of Young’s moduli examined in this study 
(Fig. 4.8). However, cell adhesion was affected by stiffness across a larger range: greater cell 
spreading and adhesion was found on polyacrylamide gels when moduli increased from 5 to 70 
kPa [146], on poly(L-lysine)/hyaluronan films (3-400 kPa) with moduli greater than 300 kPa 
[147], and on polyelectrolyte films (0.15-150 MPa) of 150 MPa [148]. 
Notably, synergistic, cooperative binding onto PVA hydrogels presenting both anti-
VCAM1 and anti-E-selectin was observed. Cooperativity may be defined as two antibodies that 
function together to produce a result not independently obtainable. We observed synergistic 
binding between IL-1α activated ECs and liposomes that present an optimal ratio of antibodies 
to relevant CAMs, a 1:1 ratio of anti-VCAM1:anti-E-selectin [85]. Liposome binding was 
inhibited by disrupting lipid raft formation and blocking of either CAM [87]. This previous work 
suggested that CAM surface density and organization may be important in cell-material 
interactions. In the present study, synergistic binding was observed on PVA hydrogels presenting 
1:1 anti-VCAM1:anti-E-selectin. Cooperativity was demonstrated by the increased relative 
retention of cells on gels presenting 1:1 anti-VCAM1:anti-E-selectin versus PVA hydrogels 
presenting anti-VCAM1 or anti-E-selectin alone. 
All hydrogels used for cell adhesion studies had similar antibody surface densities. 
Antibodies were conjugated onto aminated PVA hydrogels (as determined by 1H NMR, Table 
4.1) using carbodiimide chemistry. Our previous work has shown that this chemistry results in 
nonpreferential conjugation of antibodies to surfaces at 70% efficiency; the molecular density 
was confirmed by flow cytometry [86]. We estimate that our conjugation conferred a density of 
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700 molecules/µm2 based on the number of surface amine groups available for antibody 
conjugation and the conjugation efficiency. This is comparable to the 20-200,000 molecules/µm2 
modification density reported in previous studies on RGD modified hydrogel surfaces [145, 
177].  
Strength of cell adhesion onto hydrogel surfaces was measured by a centrifugation assay 
where we compared the number of cells that remained adhered after centrifugation at 300 × g 
relative to inversion at 1 × g (Fig. 4.11). A force of 300 × g was equal to or greater than that used 
in previous analyses of cell adhesion strength [145, 162, 163]. The PVA hydrogels modified with 
1:1 anti-VCAM1:anti-E-selectin strongly adhered ECs; a 0.9 cell retention ratio was observed. In 
comparison, the previously studied systems that most effectively adhered cells showed lower cell 
retention. For example, RGD modified interpenetrating networks composed of poly(acrylamide-
co-ethylene glycol/acrylic acid) exhibited a cell retention ratio of 0.6 for rat calvarial osteoblast 
cells centrifuged at 57 × g [163] and dinitrophenol functionalized acrylamide surfaces 
demonstrated a 0.8 cell retention ratio for rat basophilic leukemia cells centrifuged at 300 × g 
[162]. The 1:1 anti-VCAM1:anti-E-selectin PVA hydrogels presented here thus enabled stronger 
binding than functionalized materials reported in the literature and demonstrated that hydrogel 
chemistry that mimics at least two types of cell-cell interactions can facilitate stronger cell 
adhesion than that which resembles cell-matrix interactions. 
Presentation of either RGD, anti-VCAM1 or anti-E-selectin alone resulted in similar EC 
adhesion (Fig. 4.11). The dissociation constant of RGD-integrin binding was approximately 10-4-
10-6 M depending on the length of the peptide evaluated [178] whereas the disassociation 
constant of antibody-antigen binding was 10-9 M [179]. The differences in the disassociation 
constants did not correlate with overall EC adhesion; this is most likely because we measured 
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several interactions and not a single interaction. Since anti-VCAM1 and anti-E-selectin 
presenting PVA hydrogels had similar binding to RGD modified surfaces, we concluded that the 
stronger adhesion observed with 1:1 anti-VCAM1:anti-E-selectin was due to the synergy and 
cooperativity between anti-VCAM1 and anti-E-selectin.  
PVA hydrogels are non-cytotoxic, can conform to any geometry, and can be 
photocrosslinked in situ on short time scales [156, 180]. These qualities make PVA suitable as a 
vascular embolic agent for the treatment of cerebral aneurysms. In comparison to ionically 
crosslinked alginate hydrogels that have been investigated for use in endovascular embolization 
[181, 182], functionalized PVA hydrogels can not only adhere to ECs but also be tuned to match 
vascular mechanical properties. Future work will evaluate functionalized PVA hydrogels in 
vascular remodeling applications. 
   Regarding the PVA and alginate hydrogel systems discussed in this and the following 
chapter, we have shown cooperative binding of our modified hydrogels to activated ECs in vitro 
using an acute inflammatory model rather than a more physiologically relevant model. We do 
not profess that this model can be used to treat aneurysms in vivo without more experimentation; 
rather, we submit that these proof of principle experiments will lay the groundwork for using 
synergy and cooperativity in engineering cell adhesion for vascular therapies. Although we have 
shown that a 1:1 ratio of anti-VCAM1:anti-E-selectin resulted in the greatest cell adhesion to 
hydrogels, further studies should re-evaluate this ratio to better complement EC conditions in 
vivo. Additional studies should evaluate cell adhesion based on a more realistic model that takes 
hemodynamics and shear stress into account rather than a centrifugation assay. The conformation 
of the antibodies adhered to the hydrogels was also not characterized, and antibodies most likely 
adhered randomly due to the availability of multiple binding sites. Future studies may benefit 
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from controlling antibody adhesion to the hydrogel surfaces. Finally, cell seeding beyond 24 h 
was not investigated. Complementary work should determine the effect of longer seeding times 
on cell adhesion. Nonetheless, we have shown the significance of cooperative antibody 
presentation in cell adhesion. 
   We have synthesized photopolymerizable, mechanically tunable, functionalized PVA 
hydrogels. PVA hydrogels presenting a 1:1 anti-VCAM1:anti-E-selectin ratio exhibited 
synergistic and cooperative adhesion to ECs. These functionalized hydrogels may serve as ideal 
candidates for tissue engineering applications. The results of this work have been published in 
Rafat et al. Biomaterials 2012 [183]. 
 
4.8 Experimental Challenges 
  We began by modifying PVA (13-23 kDa, 98% hydrolyzed) with the glycidyl 
methacrylate side group in our initial experiments. After modification, hydrogels took more than 
90 s for gelation and were difficult to handle. We then decided to modify PVA (31 kDa) that was 
88% hydrolyzed with 2-ICEMA, which produced hydrogels with tunable properties that could all 
be polymerized in 90 sec. A subsequent challenge was that PVA modification was conducted in 
a sequential two-step process, both of which took approximately one week due to drying and 
lyophilization requirements. Moreover, the synthesized PVA had approximately 20% efficiency.  
Because of these limitations, producing large quantities of modified PVA sufficient for hydrogel 
fabrication was time-consuming. One reason we chose to examine alginate hydrogels in the next 
section was the ability to fabricate hydrogels rapidly without chemical modification. 
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5 ALGINATE HYDROGELS 
5.1 Introduction 
   Materials that adhere to the endothelial cell (EC) lining of blood vessels may be useful 
for treating vascular injury, including treatments for cerebral aneurysms. Cell adhesion 
molecules (CAMs), such as endothelial leukocyte adhesion molecule-1 (E-selectin) and vascular 
cell adhesion molecule-1 (VCAM1), modulate EC-leukocyte interactions. In this study, we 
mimicked cell-cell interactions by seeding cells on alginate hydrogels modified with antibodies 
against E-selectin and VCAM1, which become upregulated during inflammation. ECs were 
activated with interleukin-1α (IL-1α) to increase CAM expression and subsequently seeded onto 
hydrogels. The strength of cell adhesion onto gels was assessed via a centrifugation assay. 
Synergistic EC adhesion was observed on hydrogels presenting a 1:1 ratio of anti-VCAM1:anti-
E-selectin. Cell adhesion was stronger on dual functionalized gels than on gels modified with 
anti-VCAM1, anti-E-selectin, or the arginine-glycine-aspartic acid (RGD) peptide alone. Anti-
VCAM1:anti-E-selectin-modified hydrogels may be engineered to adhere the endothelium 
cooperatively. 
A fundamental challenge in tissue engineering is modulating cell adhesion as it affects 
cell migration and assembly [74]. Integrin-extracellular matrix (ECM) interactions are employed 
to regulate cell adhesion [184, 185].  For example, RGD peptides are widely used to increase cell 
attachment to materials that are characterized as non-adhesive, such as hyaluronic acid (HA) 
[186], polyvinyl alcohol (PVA) [156], and alginate [76].  
Engineering substrate surface chemistry has enabled control over cell behavior. The type 
and number of binding sites have affected cell migration and differentiation [77].  Increasing the 
molecular surface density beyond the saturation density, however, does not increase adhesion 
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strength [145]. Beyond the saturation density, it has been observed that cell adhesion can be 
controlled via multiple cooperative receptor-ligand interactions [82]. We have shown previously 
that optimal ratios of CAMs cooperatively bind drug delivery vehicles [85-87]. Enhanced cell 
adhesion was shown to be dependent on the relative molecular surface density; vehicles 
presenting an optimal anti-VCAM1:anti-E-selectin ratio that complemented EC surface 
expression showed increased binding [85]. 
To overcome the saturation of integrin-ECM interactions, we proposed to use dual 
functionalized hydrogels to strengthen cell adhesion. As a model system, we have engineered 
cellular adhesion by modifying materials with antibodies against CAMs that are upregulated on 
the surface of inflamed ECs. CAM expression is regulated by cytokine stimulation, shear stress, 
substrate mechanical properties, and cell-cell interactions [187-189]. CAMs, including E-selectin 
and VCAM1, are known to be expressed on ECs in inflammatory diseases such as 
atherosclerosis [190, 191] and cerebral aneurysms [69]. 
In this study, we hypothesized that alginate hydrogels presenting antibodies against 
VCAM1 and E-selectin may result in strong, cooperative adhesion. We measured cell retention 
as a function of time and increasing force via a centrifugation assay. We chose to evaluate 
natural alginate hydrogels in addition to the synthetic PVA hydrogels in the previous chapter due 
to their non-adhesiveness, in situ gelation, and ease of modification. Alginate hydrogels 
presented a different stiffness range as compared to PVA and were also previously implicated in 
the treatment of aneurysms [181, 182]. Engineering cell adhesion strength through the 
presentation of antibodies may be useful in improving materials design for vascular 
embolization, where binding of materials to the endothelium may be compromised by 
hemodynamic forces. 
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5.2 Methods and Materials 
Materials 
Calcium sulfate (CaSO4), alginic acid sodium salt from brown algae (alginate, medium 
viscosity), N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC), N-
hydroxysuccinimide (NHS), 2-(N-morpholino)ethanesulfonic acid hydrate (MES), and sodium 
chloride (NaCl) were purchased from Sigma Aldrich (St. Louis, MO). Hank’s Balanced Salt 
Solution (HBSS) and phosphate buffered saline (PBS) were purchased from Invitrogen 
(Carlsbad, CA). 
Alginate Hydrogel Fabrication 
Alginate was dissolved in phosphate buffered saline (PBS) to make a 2% w/v solution 
and filtered through 0.45 μm pore syringe filters. CaSO4 slurries in deionized water were 
prepared at concentrations of 0.15, 0.80, and 1.5 M. Hydrogels were fabricated by mixing 2% 
w/v alginate and a CaSO4 slurry at a 20:1 v/v ratio in connected syringes. Hydrogels were made 
either in Teflon molds (10 mm × 1 mm × 30 mm) or between two glass slides (75 mm × 50 mm 
× 1 mm) and punched out using a cork borer with a 12 mm inner diameter. All crosslinking took 
place at room temperature to enable calcium diffusion [192].  
Mechanical Properties 
Hydrogels (10 mm × 1 mm × 30 mm) were extended at a rate of 1 mm/min at room 
temperature immediately after fabrication using an Instron BioPuls machine (Instron, Norwood, 
MA). Swelling properties were evaluated as well. Hydrogels were swollen in HBSS to 
equilibrium. Mass swelling ratios (Q) were calculated by Q = WS / WD, where WS and WD are 
the masses of the swollen and dry hydrogels, respectively. 
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Cell Culture 
Human umbilical vein ECs (Lonza, Walkersville, MD) were cultured in Endothelial Cell 
Growth Medium-2 (EGM-2; Lonza). ECs were maintained at 37oC with 5% CO2 in a humidified 
incubator and grown to confluence before seeding onto hydrogels. All hydrogel formulations 
used with cells were crosslinked with 1.5 M CaSO4. 
Covalent Surface Modification of Hydrogels 
The chemical reaction scheme for covalent surface modification of alginate hydrogels is 
shown in Figure 5.1. Gels were activated for conjugation by soaking for 1 h at room temperature 
in a solution of EDC (1 mg/g alginate) and NHS (0.5 mg/g alginate) dissolved in 0.1 M MES 
buffer (pH=6.5, 0.3 M NaCl). Primary monoclonal mouse anti-human antibodies (R&D Systems, 
Minneapolis, MN) or arginine-glycine-aspartic acid-serine (RGD, Tocris Bioscience, Ellisville, 
MO) were added to the above solution at a total of 0.5 mg antibody/g alginate and allowed to 
react at 4oC overnight. Gels were rinsed with PBS before use to remove excess reactants. 
Detection of surface-conjugated antibodies was achieved by utilizing FITC-labeled goat anti-
mouse secondary antibodies (Abcam, Cambridge, MA) at 0.5 and 0.75 mg antibody/g alginate in 
conjugation reactions. Gels with conjugated primary antibodies were incubated with 
fluorescently labeled secondary antibodies (0.5 mg antibody/g alginate) for 1 h at room 
temperature. Fluorescence of modified gels relative to unmodified ones was measured using a 
Spectramax Gemini XPS microplate reader (Molecular Devices, Sunnyvale, CA) at 490 nm/525 
nm excitation/emission. Although hydrogels were modified at the same relative density, a 
limitation of this study was that we did not directly quantify the number of molecules on the 
hydrogels. 
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Figure 5.1: Chemical reaction scheme of antibody modification of alginate hydrogels. 
 
 
86 
 
X-ray Photoelectron Spectroscopy 
X-ray Photoelectron Spectroscopy (XPS) was used to characterize the chemical 
composition of the gel surface. Unmodified or anti-E-selectin-modified hydrogels were dried at 
65oC and placed on aluminum foil. Gels were analyzed on an XPS ESCA SSX-100 using a 
monochromatic Al Kα X-ray source. 
Atomic Force Microscopy 
Atomic force microscopy (AFM) imaging was used to characterize the gel surface. 
Unmodified, EDC/NHS reacted, or anti-E-selectin-modified hydrogels were dried at 65oC. Prior 
to imaging, gels were attached to glass slides with cyanoacrylate glue. Gels were imaged on an 
Asylum MFP3D Atomic Force Microscope at a frequency of 1 Hz with a MikroMasch 
Ultrasharp NSC14/AIBS Cantilever (10 nm radius, 160 kHz resonance frequency). 
Centrifugation Assay 
A centrifugation assay was used to determine the adhesion of cells onto hydrogels. This 
widely used technique evaluated the force necessary to disrupt interactions between the cells and 
hydrogels. The parameters that we used were comparable to previous studies of cell-matrix 
interactions [145, 162, 163]. Gels were seeded with 0.5 × 106 non-activated or activated ECs per 
gel for 4 or 24 h. Activated ECs were treated with 5 ng/mL IL-1α for 6 h. Serum free media was 
used during cell seeding to remove the effects of the adsorption of serum proteins on cell 
adhesion. Gels undergoing centrifugation were placed in 24 well plates filled completely with 
media in order to avoid the possible harmful effects of air bubble formation on cell retention. 
Plates were sealed with Titer-Top Plate Sealant (Electron Microscopy Sciences, Hatfield, PA), 
inverted, and centrifuged at 300, 500, or 700 × g for 10 min at 4oC. Hydrogels in plates that were 
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inverted at 4oC but not centrifuged were used as controls. Centrifugal forces were converted to a 
dislodging force, FD in dynes, using the following equation [162, 164]: FD = (ρcell-ρmedium) × Vcell 
× RCF, where ρcell is the density of the cell (1.07 g/cm3), ρmedium is the density of the medium 
(1.0 g/cm3), Vcell is the volume of the cell (diameter = 10 µm), and RCF is the relative centrifugal 
force (× g, where g = 980 dyne/g). Cells were estimated to feel between 1.1 × 10-5 and 2.5 × 10-5 
dynes when centrifuged at 300 to 700 × g. 
Following centrifugation or inversion, cells were rinsed once with PBS and trypsinized. 
A Z2 Coulter counter (Beckman Coulter, Brea, CA) was used to determine the number of cells 
adhered to gels after either centrifugation or inversion. The cell retention ratio, defined as the 
total number of cells remaining after centrifugation divided by the number of cells retained after 
inversion, was quantified for all gels. Statistically significant differences in cell retention on gel 
samples were determined using two-way ANOVA analysis.  
 
5.3 Mechanical Properties of Alginate Hydrogels 
We investigated the strength of cell adhesion onto alginate hydrogels as a function of gel 
surface chemistry. Adhesion onto alginate hydrogels presenting three different ratios of 
antibodies (1:0, 1:1, or 0:1 anti-VCAM1:anti-E-selectin) was examined. A schematic of cell 
adhesion onto antibody-modified hydogels is shown in Figure 5.2. EC binding to functionalized 
alginate hydrogels was quantified using a centrifugation assay and compared to binding on 
unmodified and RGD-modified hydrogels. 
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Figure 5.2: Schematic of cell adhesion to modified hydrogels. Arrows represent VCAM1 
(orange) and E-selectin (gray) receptors on cell surfaces. Hydrogels presenting optimized ratios 
of antibodies allow for strong adhesion between the expressed antigen and antibody. 
 
The CaSO4 concentration used for crosslinking was altered during synthesis to vary the 
elastic and swelling properties of the hydrogels. The linear-elastic region between 0-0.2 tensile 
strain of the stress-strain curve was used to determine the Young’s modulus (Fig. 5.3A). For gels 
synthesized with a 0.15 M and 1.5 M CaSO4 slurry, Young’s moduli varied between 34 ± 3 and 
70 ± 4 kPa, respectively (Fig. 5.3B). Young’s moduli increased with increasing concentrations of 
CaSO4. Swelling ratios increased as the amount of CaSO4 used in synthesis decreased (Fig. 
5.3C). All hydrogels used for cell studies were crosslinked with 1.5 M CaSO4. 
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Figure 5.3: Characterization of alginate hydrogel mechanical properties. (A) Representative 
stress-strain curve for hydrogels made with 1.5 M CaSO4. The Young’s modulus (B) and mass 
swelling ratio (C) of alginate hydrogels is dependent on the concentration of CaSO4. Error bars 
shown are standard error with n = 4. 
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5.4 Characterization of Modified Alginate Surfaces 
XPS analysis of the molecular composition of the surfaces of unmodified (Fig. 5.4A), 
anti-E-selectin gels (Fig. 5.4B), and RGD-modified gels (Fig. 5.4C) verified successful 
conjugation of antibodies. A high-resolution focus on the nitrogen 1s orbital between 395-397 
eV indicated the presence of nitrogen only in the modified gels [193] when compared to the 
unmodified condition (Fig. 5.4D). As unmodified alginate does not contain nitrogen, the increase 
in signal was attributed to the conjugation of anti-E-selectin or RGD. 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: X-ray photoelectron spectroscopy analysis of alginate hydrogels. (A) 
Unmodified, (B) anti-E-selectin-modified, and (C) RGD-modified alginate hydrogels are shown. 
Unmodified anti-E-selectin-modified 
RGD-modified High Resolution Focus of N (1s) 
A B 
C D 
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Figure 5.4 (Continued): A high resolution focus on the nitrogen 1s orbital of the unmodified 
(dashes), RGD-modified (crosses), and anti-E-selectin-modified (solid) hydrogels is shown in 
(D). 
 
Antibody conjugation to hydrogels was corroborated via AFM (Fig. 5.5). Fig. 5.5Ai presents a 
reconstructed topographical map of the unmodified gel surface. In contrast to the unmodified 
hydrogel, dense peaks of 5-10 nm in height were observed along the surface of the anti-E-
selectin-conjugated gel (Fig. 5.5Bi). The surface of unmodified and EDC/NHS reacted gels (Fig. 
5.5Ci) were relatively smooth except for surface features arising from dehydration of the gel. 
The presence of nanoscale features on anti-E-selectin-modified hydrogels was confirmed by 
cross-sectional analyses of gel surface height variation (Fig. 5.5Bii). Repeated, regular peaks and 
valleys measuring 4-6 nm were present along the cross-sectional width of the anti-E-selectin-
modified gels while the unmodified and EDC/NHS reacted gels had smoother surfaces with 
broader height variations (Fig. 5.5Aii, Fig. 5.5Cii). Surface feature heights seen in cross-
sectional analyses were consistent with prior published work regarding antibody height [194].  
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Figure 5.5: Atomic force microscopy analysis of surface modification. Determination of the 
surface properties of (A) unmodified, (B) anti-E-selectin-modified, and (C) EDC/NHS reacted 
alginate hydrogels using atomic force microscopy. (Ai), (Bi), and (Ci) are 3D topographical 
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Figure 5.5 (Continued): images (100 nm x 20 nm). (Aii), (Bii), and (Cii) are cross-sectional 
analyses of gel surface height variations for 100 nm wide sections. 
 
We additionally confirmed antibody conjugation using fluorometric methods. Secondary 
antibodies (e.g. FITC-labeled goat anti-mouse secondary antibodies) were reacted with the 
hydrogel surfaces or conjugated to mouse anti-human primary antibodies. Increasing 
fluorescence was observed with increasing quantities of secondary antibody utilized in the 
conjugation reaction (Fig. 5.6A). Similar fluorescence intensities were measured for anti-E-
selectin and anti-VCAM1 modified alginate hydrogels (Fig. 5.6B). 
 
 
 
 
 
 
 
 
 
Figure 5.6: Molecular surface density analysis. Relative fluorescence of (A) increasing 
concentrations of FITC-labeled secondary antibodies conjugated directly to the alginate surface 
and (B) secondary antibody-labeled primary antibodies conjugated to alginate at 0.5 mg 
antibody/g alginate. Error bars are reported as standard error with n = 4. 
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5.5 Dynamic Cell Adhesion 
ECs temporally upregulate VCAM1 and E-selectin in response to cytokine stimulation in 
well-characterized patterns [80]. We have previously quantified the increase in VCAM1 and E-
selectin surface expression after EC stimulation with 5 ng/mL IL-1α for 6 h [85]. Before being 
seeded onto functionalized alginate hydrogels, ECs were activated to mimic the expression of 
CAMs observed in vascular disease [80]. 
Cell adhesion onto hydrogels modified with varying ratios of anti-VCAM1:anti-E-
selectin was compared to adhesion on unmodified and RGD-modified alginate. The adhesion 
properties of non-activated ECs were first evaluated via centrifugation at 300 × g 24 h post-
seeding (Fig. 5.7). Non-activated ECs exhibited CAM-independent binding. Hydrogels modified 
with 0:1, 1:1, or 1:0 anti-VCAM1:anti-E-selectin had similar binding to the unmodified 
condition. Activated ECs were then seeded onto hydrogels for 4 or 24 h, and adhesion is 
examined via the centrifugation assay. As previously described, the cell retention ratio compares 
the number of cells adhered after gel centrifugation to the number of cells adhered after gel 
inversion [183]. Gels modified with both antibodies had the highest cell retention after 
centrifugation at 300 × g 4 h post-seeding; RGD-modified gels exhibited the lowest adhesion 
relative to modified hydrogels (Fig. 5.8A). Cell retention was greatest on alginate hydrogels 
modified with a 1:1 ratio of anti-VCAM1:anti-E-selectin than RGD, anti-E-selectin, or anti-
VCAM1-modified hydrogels after centrifugation at 300 × g 24 h post-seeding (Fig. 5.8B).  
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Figure 5.7: Unstimulated EC retention. Unstimulated ECs upon centrifugation at 300 × g 24 h 
after cell seeding onto hydrogels were examined. Cell retention ratio is defined as ratio of cells 
remaining on gels after centrifugation divided by cells retained on non-centrifuged samples. 
Error bars are reported as standard error with n = 4. No statistically significant differences were 
found between conditions using two-way ANOVA analysis. 
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Figure 5.8: Cell adhesion dynamics. Retention of ECs stimulated with IL-1α (5 ng/mL for 6 h) 
seeded onto antibody-modified hydrogels upon centrifugation at 300 × g (A) 4 h and (B) 24 h 
after cell seeding onto hydrogels. Error bars are reported as standard error with n = 4. Statistical 
significance was evaluated using two-way ANOVA with *p < 0.05, **p < 0.01, and ***p < 
0.001. Statistically significant differences in cell retention ratios were also found between  
A 
B 
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Figure 5.8 (Continued): unmodified hydrogels and RGD (p < 0.05), anti-E-selectin (p < 0.01), 
and anti-VCAM1-modified (p < 0.01) gels centrifuged 4 h after seeding as well as between 
unmodified and RGD (p < 0.05) gels centrifuged 24 h after seeding. 
 
5.6 Cell Adhesion Strength on Alginate Hydrogels 
The strength of cell adhesion was evaluated by subjecting alginate hydrogels to 
increasing centrifugation forces of up to 700 × g (2.5 x 10-5 dynes) and subsequently quantifying 
the cell retention ratio (Fig. 5.9). Cell retention on all hydrogel types decreased with increasing 
centrifugal force. However, at all centrifugation speeds, alginate hydrogels modified with a 1:1 
ratio of anti-VCAM1:anti-E-selectin exhibited the highest cell retention. Statistically significant 
differences in cell retention ratios were found between hydrogels modified with a 1:1 ratio of 
anti-VCAM1:anti-E-selectin and all other conditions. This indicated the increased strength of 
cell adhesion to dual antibody conjugated hydrogels at higher forces. 
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Figure 5.9: Cell adhesion strength. Retention of ECs stimulated with IL-1α (5 ng/mL for 6 h) 
seeded onto antibody-modified hydrogels upon centrifugation at (A) 500 × g and (B) 700 × g 24 
h after cell seeding onto hydrogels. Error bars are reported as standard error with n = 4. 
Statistical significance is calculated using two-way ANOVA analysis with *p < 0.05, **p < 0.01, 
and ***p < 0.001. Statistically significant differences in cell retention ratios were also found 
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Figure 5.9 (Continued): between unmodified hydrogels and RGD (p < 0.05), anti-E-selectin (p 
< 0.05), and anti-VCAM1-modified (p < 0.05) gels centrifuged at 500 × g. 
 
5.7 Discussion 
We have engineered a dual antibody-functionalized alginate hydrogel that exhibited 
stronger cell adhesion than hydrogels modified with antibody or RGD alone. Engineering 
cooperative EC adhesion to alginate hydrogels may be used as an alternative, minimally-invasive 
method to remodel vessels. The proposed alginate gel has the ability to form in situ by rapid 
ionic crosslinking, conform to any geometry, and adhere to ECs. These characteristics may be 
useful for space-filling applications that benefit from EC adhesion, including the occlusion of 
wide-necked or enlarged aneurysms. 
Previous studies have demonstrated that cell adhesion can be modulated by varying 
substrate stiffness. Pelham et al. showed that cell adhesion and spreading increased when the 
moduli of polyacrylamide gels increased from 5 to 70 kPa [146]. Differences in adhesion onto 
antibody functionalized PVA hydrogels with stiffnesses ranging from 170 to 450 kPa showed a 
similar trend [183].  Here, alginate hydrogels were synthesized with Young’s moduli varying 
from 34-70 kPa (Fig. 5.3). If necessary, alginate stiffness can be further tuned by altering the 
composition of guluronic and mannuronic acid [181]. The mechanical properties of the 
ascending aorta (47-76 kPa) and carotid arteries (34-63 kPa) are estimated to fall within a similar 
range [171]. Alginate hydrogel stiffness may be used to tailor cell adhesion and spreading. 
Adhesion is also dependent on cellular surface chemistry. Previous work has 
demonstrated that RGD surface density and spatial organization influences cell adhesion. 
Enhanced cell adhesion strength is attributed to reorganization of actin filaments in response to 
100 
 
RGD clustering patterns [145]. Instead of exploiting integrin-matrix interactions, we have taken 
advantage of inflammation-induced CAM overexpression to increase adhesion between the 
antibody-modified hydrogel and the endothelium. Both E-selectin and VCAM1 are upregulated 
on ECs during inflammation [61]. Cytokine activation mimics this phenomenon in vitro [80, 85]. 
We have shown previously that activated ECs exhibited maximal binding of drug delivery 
vehicles presenting a 1:1 ratio of anti-VCAM1:anti-E-selectin. Based on this prior work, we have 
conjugated three ratios of anti-VCAM1:anti-E-selectin to alginate surfaces to examine 
cooperative adhesion. Successful modification of hydrogel surfaces was confirmed using XPS, 
AFM, and fluorescence measurements of secondary antibodies (Fig. 5.4-5.6). The molecular 
density of all modified hydrogels was similar (Fig. 5.6B). 
We evaluated whether cell adhesion was time-dependent. Adhesion to RGD-modified 
surfaces after centrifugation at 300 × g increased by 18.5% between 4 and 24 h post-seeding 
(Fig. 5.8), which may be due to increasing integrin-ligand bonds over time [195, 196]. In 
contrast, cell adhesion to antibody-modified hydrogels remained similar between 4 and 24 h, 
suggesting that antibody-mediated cell binding is independent of integrin-matrix interactions. 
Dual antibody-presenting alginate hydrogels enabled cooperative adhesion to activated 
ECs. As centrifugation forces increase from 300 to 700 × g (i.e., 1.1 × 10-5 -2.5 × 10-5 dynes), 
activated EC adhesion was consistently greater on hydrogels presenting a 1:1 ratio of anti-
VCAM1:anti-E-selectin relative to anti-VCAM1, anti-E-selectin or RGD-modified hydrogels 
(Fig. 5.9). Cell retention declined by 32.2% when the force increased by 133%. 
The cell retention ratio reported herein for hydrogels with a 1:1 anti-VCAM1:anti-E-
selectin ratio was comparable to previously published work (0.6 for 700 × g). For example, a cell 
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retention ratio of 0.2 was reported when human glioma cells adhered to fibronectin-coated 
surfaces were subjected to a force of 2.8 × 10-5 dynes [197]. This force was comparable to the 
one used in our study; however, our cell retention ratio was three times greater. Furthermore, the 
retention ratio between non-activated human ECs and polymorphonuclear leukocytes was 0.6 at 
600 × g [198]. Our retention ratio was similar despite using a greater force. Cooperative adhesion 
of ECs to antibody-functionalized matrices provides an opportunity to engineer adhesion 
strength without altering number and organization of binding sites.  
We measured cell adhesion strength by modifying alginate with different ratios of anti-
VCAM1 and anti-E-selectin. At similar modification densities, hydrogels presenting a 1:1 ratio 
of anti-VCAM1:anti-E-selectin showed enhanced, synergistic cellular binding relative to those 
presenting single antibodies or RGD alone. Therefore, dual functionalized hydrogels may be 
used to engineer cell adhesion for improving current treatments for cerebral aneurysms or for 
vascular remodeling. This results of this work have been published in Rafat et al. Acta 
Biomaterialia 2012 [199]. 
 
5.8 Experimental Challenges 
Although alginate hydrogels can be fabricated more quickly than PVA, rapid crosslinking 
of alginate caused the retention of air bubbles, which resulted in uneven hydrogel densities. We 
improved our mixing technique and polymerized the gels between glass plates to minimize air 
bubble formation. A second challenge was that alginate hydrogels were not optically clear after 
cell culture, which potentially interfered with fluorescence measurements. Future work should 
dissolve alginate in MES buffer rather than PBS to minimize the cloudy appearance. 
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6 FUTURE DIRECTIONS 
   In this section, we propose future experiments that can be extended from our previous 
aims. 
6.1 Further in vitro Experiments 
3D Computational Model 
   We have collaborated with Prof. Efthimios Kaxiras to evaluate 3D aneurysm geometries. 
In this study, 3D geometries for three patients were obtained via a GE Computed Tomography 
(CT) scanner from Dr. James Rabinov at Massachusetts General Hospital and processed by 
Harvard graduate student Amanda Peters Randles and Joseph Insley from the Argonne National 
Laboratory.  The CT angiography data provided was segmented using Vitrea workstations from 
Vital Images.  The wall shear stress and velocity profiles of blood flow in the patient aneurysms 
were produced through the Lattice Boltzmann method (LBM) [200-202].  LBM is a low-Mach, 
weakly-compressible fluid solver that reproduces hydrodynamics in the continuum limit. The 
volume from the CT data was filled with a regular array of lattice points and a minimal form of 
the classical Boltzmann equation (Eq. 6.1) was solved for each lattice point. 
𝑓𝑝�𝑥 + 𝑐𝑝∆𝑡, 𝑡 + ∆𝑡� =  𝑓𝑝(𝑥, 𝑡) − 𝜔∆𝑡�𝑓𝑝 − 𝑓𝑝𝑒𝑞�(𝑥, 𝑡) + ∆𝑓𝑝(𝑥, 𝑡)  (6.1) 
Here, ω is the relaxation frequency and fpeq represents the local equilibrium distribution. The 
basic quantity fp (x, t) is the distribution function representing the probability of finding, at mesh 
location x and at time t, a “fluid particle” traveling with discrete velocity cp.  The fluid 
populations are advanced in a timestep Δt through the equation.  
   Information travels along straight lines defined by a set of discrete speeds. In this model, 
we used a D3Q19 lattice (19 speeds in 3D space).  This is shown in Figure 6.1 [203]. 
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Figure 6.1: D3Q19 stencil used in the computational model. 
    
   An advantage of LBM is that shear stress is easily calculated as a linear combination of 
the discrete populations at each lattice point as shown in Equations 6.2 and 6.3 below. 
𝑆(?⃗?𝜔, 𝑡) = �(𝜎:𝜎)(?⃗?𝜔, 𝑡) (6.2) 
𝜎(?⃗?, 𝑡) = 𝜈𝜔
𝑐𝑆
2 ∑ 𝑐𝑖𝑐𝑖�𝑓𝑖 − 𝑓𝑖
𝑒𝑞�(𝑖 ?⃗?, 𝑡) (6.3) 
where S is the shear stress, 𝜎 is the stress tensor, ν is the kinematic viscosity, and cs = 
1
√3
 is the 
speed of sound. The simulation was run at a 10 µm resolution.  The fluid kinematic viscosity is 4 
× 10-6 m2/s, and the density is 1000 kg/m3.  As in the 2D models in COMSOL, the no slip 
boundary condition was applied at the walls. We assumed 3D, steady, laminar flow in a rigid 
wall model of the vessels.  The simulations were executed at Harvard SEAS on the resonance 
GPU cluster using multi-scale physics software (MUPHY) code from Prof. Kaxiras’s group. 
   Preliminary results elucidated the velocity and shear stress profiles for all three patients 
(Figs. 6.2-6.4). In all cases, fluid flow and shear stress were markedly decreased in the aneurysm 
area. In future studies, we can conduct a systematic comparison of how changes in aneurysm 
geometry affect 3D flow patterns. 
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Figure 6.2: 3D (A) velocity and (B) shear stress data for patient 1. 
A 
B 
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Figure 6.3: 3D (A) velocity and (B) shear stress data for patient 2. 
A 
B 
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Figure 6.4: 3D (A) velocity and (B) shear stress data for patient 3. 
A 
B 
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Radiopacity 
  An important issue in designing an embolic agent is to include radiopaque properties 
since a potential treatment must be monitored in vivo. As such, contrast agents such as tantalum 
or bismuth trioxide are commonly used in the clinic [204]. To avoid the possibility of cytotoxic 
effects of the agent leaking out into the surrounding vasculature, iodine can be covalently bound 
to the modified PVA. This process has been shown previously not to interfere with hydrogel 
formation [205]. Dry PVA can be mixed with dry pyridine and stirred for 2 h. The pyridine is 
removed with a rotary evaporator. The residue is dissolved in dry DMSO at 60oC free from 
moisture. The solution is then cooled to 45oC. In dichloromethane, 4-iodobenzoyl chloride (11.5 
mmol) is added dropwise. Triethylamine is added in excess. After cooling to room temperature 
and stirring for 2 h, the solution can be added to an 80/20 solvent mixture of diethylether and 
acetone. The precipitate can be collected, washed with water, and dried under vacuum. The full 
chemical structure for the modified PVA is shown in Figure 6.5 below. 
 
Figure 6.5: Chemical structure of PVA modification to include radiopacity. Proposed PVA 
gel with an amine group for bioconjugation, a photopolymerizable group, and an iodine group 
for radiopacity. 
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Examination of in situ Polymerization 
   A novel fluidic device can be constructed in order to examine in situ polymerization of 
PVA and alginate hydrogels as well as the ability of the hydrogels to withstand hemodynamic 
forces. Soft lithography can be used to create aneurysm-shaped devices from polydimethyl 
siloxane (PDMS) [206]. Briefly, master channels of 1.5 mm height can be machined into 
Delrin blocks with representative bifurcating aneurysm geometries. The length and width of 
the daughter vessel can match the 2D computational studies at 30 mm and 3 mm, respectively. 
The length and width of the parent vessel can be set to 40 mm and 4 mm, respectively. The 
aneurysm height and width can be variable. Initial devices have height to width ratios of 0.5 
(height 1 mm, width 2 mm) and 1 (height 2 mm, width 2 mm). PDMS elastomer (Sylgard 184, 
Dow Corning) is made by mixing base to curing agent in a 10:1 ratio by mass. The elastomer is 
poured onto the master, degassed, and cured at 65oC for 1 hr. The PDMS construct can then be 
treated with oxygen plasma and adhered to a glass slide (Fig. 6.6). Inlet and outlet holes of 1.5 
mm can be made to allow for fluid flow. PDMS is an ideal material for biological flow 
experiments because of its variable elasticity, transparency, oxygen permeability, and 
biocompatibility [207]. 
 
 
 
 
 
Figure 6.6: In vitro aneurysm device. A height to width ratio of 0.5 is shown here. Scale bar is 
1.0 cm. 
109 
 
Quantification of Molecules on Modified Hydrogel Surfaces 
Although we have extensively proven successful modification and confirmed that 
modification results in the same relative molecular density on hydrogel surfaces, we have not 
quantified the exact number of molecules present on our hydrogels. Future experiments can use 
radiolabeled antibodies for the determination of molecular surface density [76]. 
 
6.2 In vivo Experiments 
   The PVA and alginate hydrogels designed in this dissertation are versatile and can be 
used for a wide variety of space-filling applications where in situ polymerization is needed. Our 
work can be extended to determine the efficacy of these hydrogels as embolic materials for the 
treatment of cerebral aneurysms. Hydrogels can be modified in bulk before gelation for in vivo 
feasibility [156]. 
   Various animal models for aneurysms have been developed in rats, mice, monkeys, and 
rabbits [15-20]. Because of vasculature size and ease of access, a rabbit model can be used in 
future in vivo procedures. Animal experiments can be performed as previously described [17]. 
New Zealand white female rabbits between 3 and 4 kg can be used. Acepromazine (1 mg/kg), 
ketamine (75 mg/kg), and xylazine (5 mg/kg) can be injected intramuscularly for the induction of 
anesthesia. The origin of the right common carotid artery (RCCA) can be exposed surgically 
while the surrounding tissue can be removed. The RCCA can be occluded distally using silk 
ligature, and a temporary clip will be placed at the RCCA origin. An angiocatheter can be used 
to administer porcine elastase into the lumen.  Upon incubation for 20 min, the area proximal to 
the cannulation site can be tied so that the clip can be released. The skin of the animal can be 
closed with vicryl suture. 21 days after aneurysm initiation, angiography can be performed to 
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assess aneurysm development. Once aneurysms are developed in rabbits, the effectiveness of 
modified PVA or alginate hydrogels can be tested in comparison to the current treatment 
methods of coiling or clipping. 
 
6.3 Dissertation Summary 
   We first used computational modeling to evaluate the effects of changing aneurysm 
geometry on flow patterns and shear stress. Based on the finding that small changes in geometry 
resulted in significant changes in flow patterns and shear stress, we then determined the effects 
of changing shear and inflammation on EC surface expression. Taken together, the results were 
used to fabricate biomaterials for aneurysm occlusion. Specifically, we designed PVA and 
alginate that could polymerize in situ, conform to any geometry, and adhere strongly and 
synergistically to activated endothelium. These results may be useful in designing new 
treatments for cerebral aneurysms. 
  Overall, this dissertation determined that the presentation of two antibodies on hydrogel 
surfaces resulted in synergistic, cooperative binding of endothelial cells. We established that 
cell adhesion onto hydrogels may be greatly enhanced by complementing activated EC surface 
expression of CAMs typically upregulated during inflammation. These findings may be 
extended to the development of therapies where firm cell adhesion is necessary, such as a 
vascular embolic agent that must withstand hemodynamic forces. 
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8.2 Appendix B: Supplement to Computational Studies 
MATLAB Code Used for COMSOL Simulations 
%Marjan Rafat with assistance from Martin Heller 
%Aneurysm Streamline Analysis 
%1 December 2007 
flclear fem 
clear 
  
% Constants 
fem.const.rho = 1060;     % density of fluid [kg/m^3] 
fem.const.eta = 3e-3;  % viscosity of fluid [Ns/m^2] 
  
fem.expr = { ... 
    'sigmaxx','-p+2*eta*ux' ... 
    'sigmaxy','eta*(uy+vx)' ... 
    'sigmayx','eta*(vx+uy)', ... 
    'sigmayy','-p+2*eta*vy'};             
  
%Geometry and mesh 
% Find the boundary groups 
c = geomdel(rect2(0.03,0.004)+rect2(0.003,0.03,'pos', [0.03;-
0.013])+ellip2(0.001,0.0005,'pos',[0.033;.002])); 
s.objs={c}; 
s.name={'channel'}; 
fem.draw = struct('s',s); 
[g,ctx] = geomcsg(fem, ... 
    'Ns',{'c'}, ... 
    'Sf','c', ... 
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    'Out',{'g','ctx'}); 
fem.geom = g; 
fem.mesh = meshinit(fem,'hauto',1,'hnarrow',4,'report','off'); 
%plot geometry 
figure; 
geomplot(fem, 'edgelabels', 'on', 'pointmode','off'); 
  
% find boundary numbers 
[i,j] = find(ctx{1}); 
inlet = i(find(j==1)); 
outlet = i(find(j==5|j==7)); 
noslip = i(find(j==2|j==3|j==4|j==6|j==8|j==9|j==10|j==11)); 
clear c s g ctx i j 
  
fem.sdim = {{'x','y'}}; 
% u, v, p, lm3, lm4 
fem.shape=[2 2 1 2 2]; 
  
% Equations 
fem.form = 'weak'; 
fem.equ.dim = {'u','v','p'}; 
fem.equ.init = {{0;0;0}}; 
fem.equ.shape = [1;2;3]; 
fem.equ.dweak = {{'rho*ut*test(u)';'rho*vt*test(v)';0}}; 
fem.equ.weak = {{'-sigmaxx*test(ux)-sigmaxy*test(uy)-
rho*(u*ux+v*uy)*test(u)'; ... 
                 '-sigmayx*test(vx)-sigmayy*test(vy)-
rho*(u*vx+v*vy)*test(v)'; ... 
                 '-(ux+vy)*test(p)'}}; 
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% Boundary conditions 
% Boundary group 1 = inlet 
% Boundary group 2 = no slip along the walls 
% Boundary group 3 = outlet 
fem.bnd.ind = {[inlet] [noslip] [outlet]}; 
fem.bnd.dim = {'u','v','p','lm3','lm4'}; 
fem.bnd.init = {{'0';'0';'0';'0';'0'}}; 
fem.bnd.shape = {[1;2;4;5], ... 
                 [1;2;3;4;5],... 
                 [1;2;4]}; 
fem.bnd.weak = {... 
    {0;0;0;'-lm3_test*(4*s*(1-s)*0.7-u)+u_test*lm3';'lm4_test*v+v_test*lm4'}, 
... 
    {0;0;0;'lm3_test*u+u_test*lm3';'lm4_test*v+v_test*lm4'},... 
    {0;0;0;'lm3_test*u+u_test*lm3';0}}; 
  
% Create an extended meshstructure 
fem.xmesh = meshextend(fem); 
fem.sol = asseminit(fem); 
  
% Solve 
fem.sol = femtime(fem, ... 
    'init',fem.sol, ... 
    'tlist',linspace(0,1,11), ... 
    'tout','tlist', ... 
    'estrat',1); 
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%Plot Pressure profile, streamlines 
figure; 
postplot(fem, 'tridata', 'p', ... 
         'trimap','jet(1024)', ... 
         'arrowdata', {'u', 'v'}, ... 
         'title', 'Surface: Pressure; Arrow: Velocity Field'); 
  
postplot(fem, ... 
         'flowdata',{'u','v'}, ... 
         'flowcolor',[1.0,0.0,0.0], ... 
         'flowstart',{[zeros(1,20),.033*ones(1,10), 
.0334*ones(1,10),.0336*ones(1,10),.0338*ones(1,10), 
.034*ones(1,10),.0345*ones(1,10), 
.035*ones(1,10),.0355*ones(1,10),.0365*ones(1,10),.037*ones(1,10)],... 
         
[linspace(0,.004,20),linspace(.0015,.0025,10),linspace(.0015,.0025,10),linspa
ce(.0015,.0025,10),linspace(.0015,.0025,10),linspace(.0015,.0025,10),linspace
(.0015,.0025,10),linspace(.0015,.0025,10), 
linspace(.0015,.0025,10),linspace(.0015,.0025,10),linspace(.0015,.0025,10)]}, 
... 
         'title','Streamline: Velocity field [m/s]'); 
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MATLAB Code for Determining Shear Stress 
%aneurysm stream function 
flclear fem 
clear 
close all 
  
% Constants 
fem.const.rho = 1060;     % density of fluid 
fem.const.eta = 3e-3;  % viscosity of fluid 
L = 0.03; W = 0.004; 
h = 0.003; l = 0.015; 
a = 0.006; b = 0.003; 
  
fem.expr = { ... 
    'sigmaxx','-p+2*eta*ux', ... 
    'sigmaxy','eta*(uy+vx)', ... 
    'sigmayx','eta*(vx+uy)', ... 
    'sigmayy','-p+2*eta*vy', ... 
    'Q','0.004*2/3*umax'};             
  
%Geometry and mesh 
e = ellip2(a,b,'pos',[L+h;0.002])-rect2(a,2*b,'pos',[L+h-
a/2;0.002],'base','center'); 
%e = ellip2(a,b,'pos',[L+h+0.00075;0.002])-rect2(0.009,0.006,'pos',[0.024,-
0.001],'base','corner'); 
r1 = rect2(L,W,'pos',[0;0],'base','corner'); 
r2 = rect2(h,l,'pos',[L; 0.002],'base','corner'); 
r3 = rect2(h,l,'pos',[L;-0.013],'base','corner'); 
s.objs={e,r1,r2,r3}; 
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s.name={'aneurysm','channel1','channel2','channel3'}; 
fem.draw = struct('s',s); 
[g,ctx,ptx] = geomcsg(fem, ... 
    'Ns',{'e','r1','r2','r3'}, ... 
    'Sf','e+r1+r2+r3', ... 
    'Out',{'g','ctx','ptx'}, ... 
    'edge','all'); 
fem.geom = g; 
figure; 
geomplot(fem, 'edgelabels', 'on', 'pointmode','off'); 
  
% the boundaries on the ellipse 
[i,j]    = find(ctx{1}); 
aneurysm = i(find(j==2|j==3))'; 
%aneurysm = i(find(j==2|j==3|j==4|j==5))'; 
  
% the boundaries on channel1 
[i,j]   = find(ctx{2}); 
inlet   = i(find(j==4)); 
up      = i(find(j==3)); 
down    = i(find(j==1)); 
  
% the boundaries on channel2 
[i,j]   = find(ctx{3}); 
outlet2 = i(find(j==3)); 
right2  = i(find(j==2)); 
left2   = i(find(j==4)); 
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% the boundaries on channel3 
[i,j]   = find(ctx{4}); 
outlet3 = i(find(j==1)); 
right3  = i(find(j==2)); 
left3   = i(find(j==4)); 
  
% round corners near aneurysm 
% node points of corners 
% [i,j]   = find(ptx{1}); 
% corners = i(find(j==1|j==2)); 
% [g2,ctx] = fillet(g,'point',[corners],'radii',0.1*a,'out',{'ctx'}); 
% fem.geom = g2; 
%  
% [i,j]   = find(ctx{1}); 
% idx = i(find(j==aneurysm(1)|j==aneurysm(2)))'; 
% aneurysm = [aneurysm,idx]; 
inlet   = inlet; 
outlet  = [outlet2,outlet3]; 
noslip1 = [down,left3]; 
noslip2 = [up,left2]; 
noslip3 = [aneurysm,right2,right3]; 
  
  
fem.mesh = meshinit(fem, ... 
    'hauto',1, ... 
    'hnarrow',4, ... 
    'report','off', ... 
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    'hmaxedg',[aneurysm; repmat(5e-5,size(aneurysm))]); 
% meshplot(fem) 
% return 
clear c s g ctx i j %g2 
  
fem.sdim = {{'x','y'}}; 
fem.dim = {'u','v','p', 'psi','lm1','lm2'}; 
fem.shape=[2 2 1 2 2 2]; 
  
% Equations 
fem.form = 'general'; 
fem.equ.dim = {'u','v','p','psi'}; 
fem.equ.init = {{0;0;0;0}}; 
fem.equ.shape = [1;2;3;4]; 
  
% da * ut = nabla . Ga + f 
fem.form = 'general'; 
fem.equ.da = {{{'-rho'} ... 
               {'-rho'} ... 
               {'0'} ... 
               {'0'}}}; 
fem.equ.ga = {{{'sigmaxx' 'sigmaxy'} ... 
               {'sigmayx' 'sigmayy'} ... 
               {'0' '0'} ... 
               {'psix' 'psiy'}}}; 
fem.equ.f = {{{'rho*(u*ux+v*uy)'} ... 
              {'rho*(u*vx+v*vy)'} ... 
              {'ux+vy'} ... 
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              {'-(vx-uy)'}}}; 
fem.bnd.expr = {'K_x_ns','eta*(2*nx*ux+ny*(uy+vx))', ... 
                'K_y_ns','eta*(nx*(vx+uy)+2*ny*vy)', ... 
                'T_x_ns','nx*sigmaxx+ny*sigmaxy', ... 
                'T_y_ns','nx*sigmayx+ny*sigmayy'}; 
           
% Boundary conditions 
fem.bnd.ind = {[inlet] [noslip1] [noslip2] [noslip3] [outlet]}; 
fem.bnd.dim = {'u','v','p','psi','lm1','lm2'}; 
fem.bnd.init = {{'0';'0';'0';'0';'0';'0'}}; 
fem.bnd.shape = {[1:6] [1:6] [1:6] [1:6] [1:5]}; 
fem.bnd.weak = {{'lm1_test*(u-4*s*(1-s)*umax)+u_test*lm1' 
'lm2_test*v+v_test*lm2'} ... 
                {'lm1_test*u+u_test*lm1' 'lm2_test*v+v_test*lm2'} ... 
                {'lm1_test*u+u_test*lm1' 'lm2_test*v+v_test*lm2'} ... 
                {'lm1_test*u+u_test*lm1' 'lm2_test*v+v_test*lm2'} ... 
                {'lm1_test*u+u_test*lm1'}}; 
fem.bnd.constr = {0 {'psi'} 0 0 0};             
          
fem = flform(fem,'outform','weak'); 
  
fem.xmesh = meshextend(fem); 
fem.sol = asseminit(fem); 
  
% solve for different max-velocities 
fem.sol = femnlin(fem, ... 
    'pname','umax', ... 
    'plist',[.7]); 
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figure; 
postcrossplot(fem,1,[aneurysm], ... 
              'lindata','K_x_ns*(tx)+K_y_ns*(ty)', ... 
              'title','Wall Shear Stress Profile', ... 
              'axislabel',{'Arc-length','Wall Shear Stress (N/m^2)'}, ... 
              'refine','auto','solnum',1,'linlegend','off'); 
% figure; 
% postcrossplot(fem,1,[aneurysm], ... 
%               'lindata','K_x_ns*(tx)+K_y_ns*(ty)', ... 
%               'title','Wall Shear Stress Profile', ... 
%               'axislabel',{'Arc-length','Wall Shear Stress (N/m^2)'}, ... 
%               'refine','auto','solnum',2,'linlegend','off'); 
% figure; 
% postcrossplot(fem,1,[aneurysm], ... 
%               'lindata','K_x_ns*(tx)+K_y_ns*(ty)', ... 
%               'title','Wall Shear Stress Profile', ... 
%               'axislabel',{'Arc-length','Wall Shear Stress (N/m^2)'}, ... 
%               'refine','auto','solnum',3,'linlegend','off');    
figure; 
postplot(fem, ... 
        'flowdata',{'u';'v'}, ... 
        'flowcolor',[0.2,0.2,0.2],... 
        
'flowstart',{[repmat(0.033,1,21),linspace(0,a,21)+0.033,linspace(0,a,21)+0.03
3]; ... 
                     
[linspace(0,0.004,21),zeros(1,21)+0.1*b+0.002,zeros(1,21)-0.1*b+0.002]}, ... 
        'axis',[0.03+0.5*0.003 0.033+1.05*a -0.002 0.006],'solnum',1); 
% figure; 
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% postplot(fem, ... 
%         'flowdata',{'u';'v'}, ... 
%         'flowcolor',[0.2,0.2,0.2],... 
%         
'flowstart',{[repmat(.033,1,21),linspace(0,a,21)+.033,linspace(0,a,21)+.033]; 
... 
%                      
[linspace(0,.004,21),zeros(1,21)+0.1*b+.002,zeros(1,21)-0.1*b+.002]}, ... 
%         'axis',[.03+0.5*.003 .033+1.05*a -.002 .006],'solnum',2); 
% figure; 
% postplot(fem, ... 
%         'flowdata',{'u';'v'}, ... 
%         'flowcolor',[0.2,0.2,0.2],... 
%         
'flowstart',{[repmat(.033,1,21),linspace(0,a,21)+.033,linspace(0,a,21)+.033]; 
... 
%                      
[linspace(0,.004,21),zeros(1,21)+0.1*b+.002,zeros(1,21)-0.1*b+.002]}, ... 
%         'axis',[.03+0.5*.003 .033+1.05*a -.002 .006],'solnum',3); 
% figure; 
% postcrossplot(fem,1,[aneurysm], ... 
%               'lindata','K_x_ns*(tx)+K_y_ns*(ty)', ... 
%               'title','Wall Shear Stress Profile', ... 
%               'axislabel',{'Arc-length','Wall Shear Stress (N/m^2)'}, ... 
%               'refine','auto','solnum','end','linlegend','off'); 
% figure; 
% postcrossplot(fem,1,[noslip3], ... 
%               'lindata','K_x_ns*(tx)+K_y_ns*(ty)', ... 
%               'title','Wall Shear Stress Profile (tx,ty)', ... 
%               'axislabel',{'Arc-length','Wall Shear Stress (N/m^2)'}, ... 
%               'refine','auto','solnum','all','linlegend','on'); 
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% figure; 
% postcrossplot(fem,1,[noslip3], ... 
%               'lindata','K_x_ns*(-ny)+K_y_ns*(nx)', ... 
%               'title','Wall Shear Stress Profile (-ny,nx)', ... 
%               'axislabel',{'Arc-length','Wall Shear Stress (N/m^2)'}, ... 
%               'refine','auto','solnum','all','linlegend','on');           
%{           
figure; 
postcrossplot(fem,1,[aneurysm], ... 
              'lindata','T_x_ns', ... 
              'title','Total stress x-direction', ... 
              'axislabel',{'Arc-length','x-Stress (N/m^2)'}, ... 
              'refine','auto','solnum','all','linlegend','on');   
  
figure; 
postcrossplot(fem,1,[aneurysm], ... 
              'lindata','T_y_ns', ... 
              'title','Total stress y-direction', ... 
              'axislabel',{'Arc-length','y-Stress (N/m^2)'}, ... 
              'refine','auto','solnum','all','linlegend','on');   
  
figure; 
postcrossplot(fem,1,[aneurysm], ... 
              'lindata','-lm1', ... 
              'title','Total stress x-direction (lagrange multiplier)', ... 
              'axislabel',{'Arc-length','x-Stress (N/m^2)'}, ... 
              'refine','auto','solnum','all','linlegend','on');   
figure; 
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postcrossplot(fem,1,[aneurysm], ... 
              'lindata','-lm2', ... 
              'title','Total stress y-direction (lagrange multiplier)', ... 
              'axislabel',{'Arc-length','y-Stress (N/m^2)'}, ... 
              'refine','auto','solnum','all','linlegend','on');             
figure; 
postsurf(fem, ... 
    'sqrt(u*u+v*v)', ... 
    'contdata','psi', ... 
    'contlevels',11, ... 
    'contbar','off'); 
%} 
%figure; 
% fig = 0; 
% for s = fem.sol.plist, 
%     fig = fig + 1; 
%     subplot(3,3,fig); 
%     postplot(fem, ... 
%         'flowdata',{'u';'v'}, ... 
%         
'flowstart',{[repmat(L+h,1,21),linspace(0,a,21)+L+h,linspace(0,a,21)+L+h]; 
... 
%                      [linspace(-W/2,W/2,21),zeros(1,21)+0.1*b,zeros(1,21)-
0.1*b]}, ... 
%         'axis',[L+0.5*h L+h+1.05*a -W W],'solnum',fig); 
%     subplot(3,3,fig); 
%     title(['u_{max} = ' num2str(s)]); 
%     box on 
% end  
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Additional Streamline Mapping Results 
 
 
Figure 8.1: Additional mapping of flow patterns for symmetric aneurysms. Flow maps are 
shown in terms of various aneurysm height to width (HA/WA) ratios, Reynolds numbers (Re), 
and neck to parent width (WN/WP) ratios for symmetric aneurysms: (A) HA/WA=1.25 and (B) 
HA/WA=1.5. Dashed lines indicate physiological Re. 
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Figure 8.2: Additional mapping of flow patterns for offset aneurysms. Flow maps are shown 
in terms of various aneurysm height to width (HA/WA) ratios, Reynolds numbers (Re), and neck 
to parent width (WN/WP) ratios for offset aneurysms: (A) HA/WA=1.25 and (B) HA/WA=1.5. 
Dashed lines indicate physiological Re. 
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Figure 8.3: Additional mapping of flow patterns for sidewall aneurysms. Flow maps are 
shown in terms of various aneurysm height to width (HA/WA) ratios, Reynolds numbers (Re), 
and neck to parent width (WN/WP) ratios for sidewall aneurysms: (A) HA/WA=1.25 and (B) 
HA/WA=1.5. Dashed lines indicate physiological Re. 
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